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I Introduction 
Natural products have been used for the treatment of human diseases for thousands of 
years and continue today to play an important role in drug discovery and development. 
Numerous natural products are used as drugs as such while others have been synthetically 
modified. Furthermore, many of the totally synthetic drugs are designed with inspiration 
from a pharmacophore found in a natural compound. Of all the new drugs approved 
between 1981 and 2010 almost 27% are either natural products or semisynthetic 
derivatives.
1
 For anticancer and antibacterial drugs the corresponding percentages are 34% 
and 65%, respectively. 
Abietanes are naturally occurring diterpenoids found in diverse plant species where they 
play an important part in the chemical defense of the plant. Members belonging to this 
compound class exhibit a wide range of biological activities including antimicrobial, 
antiulcer, antitumor, antiviral and anti-inflammatory.
2, 3 
Dehydroabietic acid is one of the 
most abundant bioactive abietanes, readily available from disproportionate rosin.
4
 
Consequently, dehydroabietic acid is an attractive target for semisynthetic design in search 
for novel therapeutic agents.  
Oxidation is one of the major transformations in organic chemistry and provides a way for 
transforming simple chemicals into versatile building blocks or valuable fine chemicals. 
Traditional inorganic stoichiometric oxidizing agents such as manganese salts and 
chromium (VI) compounds are still relied on in both academia and industry, even though 
these oxidants are highly toxic and environmental pollutants. During the last decades, 
environmentally friendly alternatives have been extensively studied with the development 
of numerous mild oxidation procedures using nonpolluting oxidants such as molecular 
oxygen and hydrogen peroxide.
5
 
In this Master’s thesis work the benzylic oxidations of dehydroabietic acid derivatives are 
investigated. The literature part presents reported methods for the benzylic oxidations of 
dehydroabietanes as well as transition metal free benzylic oxidations of simple alkylarenes. 
The exploration of an environmentally friendly and cost-effective procedure for the 
benzylic oxidation of dehydroabietic acid derivatives, using a cheap and readily available 
oxidant, is described in the experimental part. 
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1 Abietanes 
Abietanes are naturally occurring tricyclic C20 diterpenes with the characteristic carbon 
framework 1 shown in Figure 1. Compounds of this class exist all over the plant kingdom 
where they display important eco-physiological functions. The main physical and chemical 
defense of pines (genus Pinus) is the production of the viscous secrete oleoresin (or simply 
resin), a complex mixture of mono-, sesqui-, and diterpenoids.
6
 This secrete is hardened by 
exposure to air and forms a physical barrier on the injured part of the wood after the 
volatile mono- and sesquiterpenes have evaporated. The solid residue known as rosin or 
colophony is mainly composed of resin acids of the abietane- and pimarane-type. Rosin is 
the main natural source of abietane acids such as abietic acid (2), its isomers levopimaric 
(3), palustric (4), and neoabietic acid (5), as well as dehydroabietic acid (6) (Figure 1).
2
 
Abietanes are present in the resins and extracts produced by different conifers (division 
Pinophyta), but also by several angiosperm species. 
 
Figure 1. Abietane numbering system (IUPAC) and structure of abietanes found in pine rosin.
2
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In addition to physical defense, resin provides chemical defense in being toxic to 
herbivores and pathogens plaguing the conifers.
6
 Folk medicine has used resin and its 
derivatives for thousands of years, particularly in the treatment of wounds and other skin 
injuries. Studies on the biological activities of pure abietanes isolated from resins have 
revealed interesting activities such as antimicrobial and anti-inflammatory.
2
 Today, the 
number of known natural abietane-type diterpenes continues to increase as different plants 
are systematically screened for the presence of bioactive compounds.
7
 Some of the 
abietanes are especially abundant in nature and even commercially available. Owing to the 
inherent biological activities and availability of abietanes, this family of natural products 
has gained widespread interest in both the synthetic, pharmaceutical and medical 
communities. 
1.1 Dehydroabietanes 
In the late 1930s, two different abietanes with an aromatic C-ring, dehydroabietic acid 
(abieta-8,11,13-trien-18-oic acid, 6)
8
 and ferruginol (abieta-8,11,13-triene-12-ol, 7)
9
  
(Fig. 2) were discovered. Dehydroabietic acid (6) was originally obtained in a study on the 
chemical transformations of abietic acid (2), but its isolation from natural sources (resin of 
Pinus Palustris) was not reported until 10 years later.
10
 Ferruginol (7) was isolated from 
the resin produced by the Miro tree (Podocarpus ferrugineus), endemic to New Zealand.
9
 
The structures of both abietanes were determined on the basis of chemical data. 
Abietanes with an aromatic C-ring are commonly known as dehydroabietanes. The 
majority of all the naturally occurring abietanes belong to this group of diterpenes with 
roughly two hundred compounds characterized until present.
3
 The structural diversity 
among the dehydroabietanes is astonishing and some representative members are shown in 
Figure 2. Most of the aromatic abietanes display different degrees of oxidation usually on 
rings B and C, but also on ring A as in hinokiol (abieta-8,11,13-triene-3β,12-diol) (13). 
Dehydroabietanes contain either three or four double bonds and can be subdivided 
accordingly into abietatrienes and abietatetraenes, such as salvinolone (11,12-dihydroxy-
abieta-5,8,11,13-tetraen-7-one) (14). Some of the dehydroabietanes have tetracyclic 
structures with the fourth ring generally in the form of a lactone as in carnosol  
(11,12-dihydroxy-abieta-8,11,13-trien-20,7-olide) (15), a compound found in the herbs 
sage (Salvia officinalis) and rosemary (Rosmarinus officinalis). Other tetracyclic 
dehydroabietanes contain a cyclic ether. 
4 
 
 
Figure 2. Some naturally occurring aromatic abietanes.
3
 
1.2 Biological activities of dehydroabietanes 
Lately, the biological activities of dehydroabietanes have been very actively studied. In a 
recent review, González describes the bioactivities for this class of natural products 
published between the 1980s and 2014.
3
 For dehydroabietic acid (6) alone antiulcer, 
antimicrobial, antitumour, anti-inflammatory and gastroprotective
11
 activities have all been 
reported. On the other hand, C-7 and C-15 oxidized metabolites of dehydroabietic acid 
have been identified as contact allergens and are believed to be responsible of the skin 
sensitizing properties of rosin. 
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The rapid development of multi-drug resistant microbes results in an increasing number of 
untreatable infectious diseases worldwide. Consequently, the development of new, 
effective antimicrobials is necessary. Due to the known antimicrobial properties of resin, 
aromatic abietanes have been extensively studied for their antimicrobial activities and 
some common structural features among the antimicrobial dehydroabietanes have been 
observed.
3
 The presence of a carboxylic acid group at C-18 or C-20 is responsible for the 
antimicrobial properties of compounds such as dehydroabietic acid (6), pisiferic acid  
(12-hydroxyabieta-8,11,13-trien-20-oic acid) (9) and other closely related diterpenes.
3, 12
 
On the other hand, phenolic dehydroabietanes such as ferruginol
 
(7)
12, 13
 and sugiol  
(12-hydroxyabieta-8,11,13-trien-7-one) (8) are also antimicrobial even though these 
compounds do not possess a carboxylic acid group. The antimicrobial activity is instead 
attributed to the presence of a hydroxyl group at C-12. 
Other common biological properties among dehydroabietanes are antiviral and antitumour 
activities.
3
 The majority of the antiviral dehydroabietanes contain a carboxylic acid group 
at C-19 as in the structures of callitrisic acid (abieta-8,11,13-trien-19-oic acid) (10) and the 
related metabolite angustanoic acid F (15-hydroxyabieta-8,11,13-trien-19-oic acid) (11). 
Dehydroabietanes with antitumour activity are structurally more diverse and include 
compounds such as dehydroabietic acid (6), ferruginol (7), sugiol (8), pisiferic acid (9), 
salvadoriol (6,14-dihydroxyabieta-8,11,13-trien-18-oic acid) (12), salvinolone (14),
14
 
carnosol (15) and related metabolites. 
Because the inherent activities of natural abietanes are commonly low or marginal 
compared with pharmaceutical agents in use, much research focuses on the derivatisation 
of the parent natural product in hope to find compounds with enhanced activities and 
potential use as pharmaceuticals.
15
 Dehydroabietic acid (6) is a particularly attractive target 
for semisynthetic modification due to its ready availability. Dehydroabietic acid is the 
main component of disproportionated rosin
4
 from which it is easily isolated. The synthetic 
modifications of dehydroabietic acid mainly focus on the functionalisation of rings B and 
C, in addition to modification of the functionality at C-18. The synthesis of numerous 
novel derivatives with promising activities has been reported and in 1985 Wada et al. 
discovered 12-sulfodehydroabietic acid monosodium salt with exceptionally high antiulcer 
activity.
16
 Later, this discovery led to the development of the drug ecabet
®
 which is 
marketed in Japan for the treatment of peptic ulcer disease and reflux oesophagitis.
17
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2 Benzylic C–H oxidations of dehydroabietanes 
The core structure of aromatic abietanes contains two benzylic positions available for 
modification, a cyclic secondary C-7 methylene and the exocyclic tertiary C-15. Benzylic 
methylenes show enhanced reactivity in comparison to simple alkanes due to the 
resonance-stabilizing effect of the adjacent π system which donates electron-density to the 
intermediate radical or cationic species. Consequently, dehydroabietanes can easily be 
oxidized at positions C-7 and C-15 and a number of studies have revealed that the 
secondary C-7 is more prone for oxidation, probably due to steric reasons. 
The oxidation of benzylic C–H of aromatic abietanes is a highly important chemical 
transformation for three reasons. First, oxygenation at C-7 and C-15 is a common 
structural feature among naturally occurring dehydroabietanes (Figure 2) and many of 
these natural products display important biological activities, as previously discussed. 
These compounds are usually not available in large amounts from natural sources and the 
isolation can be very difficult and expensive. Instead they can be prepared 
semisynthetically from commercially available abietanes or related compounds such as 
abietic (2), dehydroabietic (6) or podocarpic acid, or by total synthesis.
18 
In several 
reported syntheses of natural aromatic abietanes, introduction of oxygen at C-7 and C-15 
has been achieved with benzylic oxidation. 
Secondly, the 7-oxo compounds are required as intermediates in the synthesis of some 
naturally occurring abietanes even when the target molecule itself is lacking oxygenation at 
C-7.
19–21
 To create the desired ring B functionalisation, the cyclic ketone undergoes further 
reactions, for instance, reduction to alcohol followed by dehydration is an useful route for 
the synthesis of abietatetraenes with a Δ6 double bond. 
Thirdly, the 7-oxo compounds are versatile building blocks and act as key intermediates in 
the synthesis of many novel abietane derivatives, such as oximes
22, 23
 and heterocyclic 
derivatives,
24, 25
 in the search for potent pharmaceutical agents. C-15 oxygenated abietanes, 
on the other hand, are useful intermediates in the synthesis of 13-hydroxy-8,11,13-
podocarpatriene derivatives.
26, 27
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In this chapter the reported procedures for benzylic C–H oxidations of aromatic abietanes 
are discussed. The importance of this chemical transformation is highlighted by presenting 
several synthetic procedures for the preparation of naturally occurring dehydroabietanes as 
well as novel unnatural dehydroabietic derivatives which involve the benzylic oxidation as 
a key step. 
2.1 Aerobic oxidation 
Aerobic oxidation involves the oxidation with molecular oxygen by a free-radical 
mechanism. The reaction is catalyzed by radical initiators such as dibenzoyl peroxide 
(BPO) and α,α’-azoisobutyronitrile (AIBN) that decompose easily to give free radicals. 
Benzylic oxidations with O2 are also catalyzed by several metals such as cobalt
28 
and 
copper
29
. Even then, high reaction temperatures and/or extended reaction times are 
required for the oxidation to be efficient. The use of molecular oxygen as the terminal 
oxidant is nevertheless highly desirable because O2 is cheap, readily available, 
environmentally friendly with water as the only by-product, and it has a high atom 
efficiency.
30
 However, the use of O2 is hampered by fire and explosion hazards. 
Ritche et al. reported the first aerobic oxidations of methyl dehydroabietate (16) and its  
7-oxo derivative 17 in the 1950s (Scheme 1).
31, 32
 Treatment of the molten ester 16 at 80 °C 
for 43 h with molecular oxygen and 2.4 mol% BPO yielded methyl 7-oxodehydroabietate 
(17) and methyl 7-hydroperoxydehydroabietate (18), in 25% and 29% yields, respectively, 
together with a small amount of methyl 15-hydroperoxydehydroabietate (19). The 
oxidation of compound 17 in the presence of 2.5 mol% BPO at 90 °C for 29 h gave a 
mixture of products containing 49% of the 15-hydroperoxy-7-oxo compound 20, from 
which it was not isolated but instead, treated with 1% HClO4 in AcOH to afford compound 
21 in 30–35% yield. 
8 
 
 
Scheme 1. Ritchie’s aerobic oxidation of methyl dehydroabietate (16) and methyl  
7-oxodehryoabietate (17).
31, 32
 
Recently, N-hydroxyphthalimide (NHPI) has received much attention as a very efficient 
organocatalyst for aerobic oxidations of various organic compounds.
33
  
N-Hydroxyphthalimide is used to generate the phtalimido N-oxyl (PINO) radical in situ 
which is able to abstract a proton from the organic substrate (Scheme 2). After proton 
abstraction the organic radical undergoes oxidation and a hydroperoxide is formed as the 
initial product while the PINO radical is regenerated. Radical α-H abstraction34 or redox 
decomposition
35
 converts the hydroperoxide into oxygenated products such as alcohols, 
aldehydes, ketones and carboxylic acids. A metal co-catalyst or a radical initiator is usually 
added to catalyze the initial reaction step where NHPI is activated and the PINO radical is 
formed. 
9 
 
 
Scheme 2. Mechanism of the aerobic oxidation of organic substrates catalyzed by NHPI.
33 
Ritchie’s aerobic oxidation requires harsh reaction conditions and suffers from low yields. 
In order to develop a milder procedure, Matsushita et al. studied the aerobic oxidation of 
dehydroabietanes catalyzed by N-hydroxyphthalimide (NHPI) in combination with 
different co-catalysts.
26
 Initially, the group investigated the use of cobalt(II) acetate as a 
co-catalyst. The oxidation of 16 at 30 °C for 48 h (entry 1 in Table 1) gave a mixture of 
methyl 7-oxodehydroabietate (17), methyl 15-hydroperoxy-7-oxodehydroabietate (20), 
methyl 15-hydroxy-7-oxoabieta-8,11,13-trien-18-oate (22) and methyl 13-acetyl- 
7-oxopodocarpa-8,11,13-trien-15-oate (23) in 6%, 24%, 44% and 14% yields, respectively. 
By changing the temperature and reaction time they were able to affect the product 
distribution. An increase in the reaction temperature (entry 2) yielded only products 22 
(55%) and 23 (20%) with a higher degree of oxidation. A shorter reaction time (entry 3) or 
a lower reaction temperature (entry 4) gave the opposite result with formation of 17 and 20 
as the major products. 
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Table 1. Matsushita’s Aerobic oxidation of methyl dehydroabietate (16) catalyzed by NHPI and 
Co(OAc)2.
26
 
Entry Temp (°C) Time (h) Isolated yield (%) 
   17 20 22 23 
1 30 48 6 24 44 14 
2 50 48 0 0 55 20 
3 30 24 40 38 13 Trace 
4 23 48 41 34 7 Trace 
 
Next, Matsushita and his coworkers examined the use of 2,2´-azobis(4-methoxy-2,4-
dimethylvaleronitrile) (V-70) as the co-catalyst. The oxidation of methyl dehydroabietate 
16 at 30 °C for 48 h gave once more a complex product mixture of compounds 17, 18, 19 
and 20 in 16%, 8%, 10% and 41% yields, respectively (Scheme 3). However, this mild 
procedure proved to be an efficient way for the preparation of the hydroperoxide 20 in 
90% yield when oxidizing compound 17 under similar conditions. Accordingly, the group 
developed a two-step synthesis of hydroperoxides 20 and 26 in overall yields 63% and 
69% (Scheme 3). In the first step the benzylic oxidation of compounds 16 and 24 with  
tert-butyl hydroperoxide (t-BuOOH) catalyzed by 5% Ru/C gave the 7-oxo-intermediates 
17 in 70% yield and 25 in 78% yield. 
11 
 
 
Scheme 3. Matsushita’s aerobic oxidation of dehydroabietanes catalyzed by NHPI and V-70. 
Reagents and conditions: (a) O2 (1 atm), NHPI (1.0 eq), V-70 (0.20 eq), CH3CN, 30 °C, 48 h; (b) 
5% Ru/C, t-BuOOH/nonane, EtOAc, 40 °C, 12 h, 70–78%.26 
Finally, the hydroperoxides 26 and 20 proved to be useful intermediates in the synthesis of 
four different natural products: the 15-hydroxydehydroabietanes 27
36
 and 28
37
 as well as 
the podocarpane-type norditerpenoids 34
38
 and 35
39
 (Scheme 4). Reduction of 
hydroperoxides 20 and 26 with (MeO)3P yielded the 15-hydroxyabietanes 22 and 27 in 
quantitative yield. The former was hydrolyzed with NaOH to give 28 in 83% yield. 
Starting from dehydroabietane (24) and methyl dehydroabietate (16) the group synthesized 
the 15-hydroxyabietanes 27 and 28 in 69% (over 4 steps) and 52% (over 5 steps) total 
yields, respectively. 
The synthesis of podocarpanes 35 and 34 from the hydroperoxides 20 and 26 started with 
acetylation to give compounds 29 (96%) and 30 (quantitative), followed by a 
rearrangement reaction in AcOH at 100 °C to afford compounds 31 (90%) and 32 (92%). 
Reduction with triethylsilane gave compound 33 (72%) and the naturally occurring 
compound 34 in 75% yield.  Base hydrolysis of compound 33 gave the regioisomer of 
podocarpic acid 35 in 89% yield. 
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Scheme 4. Matsushita’s synthesis of naturally occurring diterpenoids and norditerpenoids. 
Reagents and conditions: (a) (MeO)3P, CH2Cl2, rt, 2 h, quantitative; (b) NaOH, EtOH, reflux, 8 h, 
83% (28), 89% (35); (c) Ac2O, DMAP, CH2Cl2, rt, 24 h, 96% (29), quantitative (30); (d) AcOH, 
100 °C, 1 h, 90% (31), 92% (32); (e) Et3SiH, CF3COOH, rt, 14 h, 72% (33), 75% (34).
26
 
2.2 Oxidation with chromium (VI) compounds 
The oxidation states of chromium compounds range from –II to +VI, with oxidation states 
+III and +VI being the most common.
40
 The oxidation state +III is energetically the most 
stable one and trivalent chromium is also essential for the metabolism of mammals.
41, 42
 
While Cr(III) compounds have generally low toxicity, chromium (VI) compounds are 
highly toxic and carcinogenic with the respiratory tract as the major target organ.
43, 44
 
However, chromium (VI) compounds are highly exploited in organic chemistry because 
these are strong oxidizing agents.  Cr(VI) compounds are capable of oxidizing various 
organic compounds while itself being reduced to the more stable +III oxidation state.
45
 
There are many different Cr(VI) reagents available for the oxidation of benzylic methylene 
groups including chromium trioxide in AcOH,
46
 sodium dichromate (Na2Cr2O7) in AcOH,
 
47, 48
 pyridinium chlorochromate (PCC),
49, 50
 pyridinium dichromate t-BuOOH
51
 and  
3,5-dimethylpyrazolium fluorochromate(VI)
52
. Some of these Cr(VI) compounds and 
others have been used for the oxidation of aromatic abietanes which is the topic of the 
discussion below. 
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Chromium trioxide (CrO3) is the anhydride of chromic acid (H2CrO4). When CrO3 is 
dissolved in AcOH it forms H2CrO4, which is a powerful oxidant. Continuing their studies 
on oxidations of aromatic abietanes, Ritchie et al. were the first to describe a chromic acid-
mediated benzylic oxidation of dehydroabietanes in 1954.
32
 Oxidation of 16 with CrO3  
(1.3 eq) in AcOH at 50 °C during the addition of CrO3, followed by stirring at room 
temperature afforded 17 in 29% yield together with the recovery of starting material 
(37%). The yield of 17 is only slightly higher compared with that obtained in their earlier 
report on the aerobic oxidation (25%).
31
 However, the yield is improved considerably for 
this substrate when CrO3 is used together with acetic anhydride Ac2O in AcOH according 
to the procedure reported by Monteiro et al. (Scheme 5).
53
 CrO3 is much more soluble in 
Ac2O than in AcOH.
54
 This oxidation afforded 17 in 67% yield together with the formation 
of minor products 23 (4%) and 36 (6%).  
 
Scheme 5. Monteiro’s chromic acid oxidation of methyl dehydroabietate (16).53 
The synthesis of several naturally occurring abietanes containing the 7-oxo functionality 
involves benzylic oxidation with CrO3 in AcOH.
18
 Abietanes that contain electron-
donating substituents like hydroxyl or methoxy groups on the aromatic ring C generally 
give the 7-oxo products in high yields even in the absence of Ac2O. The chromic acid 
oxidation is often the method of choice for making the 7-oxo compounds when needed as 
intermediates in the preparation of semisynthetic derivatives from dehydroabietanes. 
Illustrative examples of the usefulness of dehydroabietanes oxidized at position 7 are given 
below. 
In 2001 Tada et al. reported the first synthesis of demethylcryptojaponol (42)
55
 along with 
the synthesis of twelve other naturally occurring abietanes (Scheme 6).
56
 The research 
group evaluated the biological activities of these compounds against methicillin-resistant 
Staphylococcus aureus and vancomycin-resistant Enterococcus. Of the six abietanes that 
14 
 
showed potent activity against both bacterium, demethylcryptojaponol (42) and 
salvinolone (14)
57, 58
 contained the 7-oxo functionality, which was introduced by benzylic 
oxidation with chromic acid. Starting from the acid 37, which preparation via polyene 
cyclization the authors had earlier reported,
59
 the isopropyl group was introduced by 
Friedel-Crafts alkylation to give compound 38. Decarboxylation followed by 
hydrogenation of the Δ6 double bond afforded compound 39. Demethylation, oxidation 
with BPO and acetylation yielded compound 40, which was oxidized to the 7-oxo 
intermediate 41 with CrO3 in AcOH, in 66% yield. Demethylcryptojaponol (42) was 
obtained after hydrolysis of 41 with NaHCO3 in 23% total yield over 8 steps starting from 
37. Chlorination of 41 with sulfuryl chloride in CCl4 gave the chloroketone 43 which upon 
treatment with LiCl and base hydrolysis gave salvinolone (14), in 20% total yield, over 9 
steps starting from 37. 
 
Scheme 6. Tada’s synthesis of natural products demethylcryptojaponol (42) and salvinolone (14). 
Reagents and conditions: (a) i-PrCl, AlCl3, CH2Cl2, 40 °C, 40 h, 81%; (b) Pb(OAc)4, Cu(OAc)2, 
quinoline, 125 °C, 16 h, 87%; (c) H2, Pd/C, EtOAc, rt, 98%; (d) BBr3, CH2Cl2, 0–5 °C, 2 h, 95%; 
(e) BPO, CHCl3, rt, 7 h, 71%; (f) isopropenyl acetate, TsOH, PhMe, reflux, 5 h, 77%; (g) CrO3  
(2 eq), AcOH, rt, 8 h, 66%; (h) NaHCO3, MeOH/H2O, reflux, 96%; (i) SO2Cl2, CCl4, 60 °C, 40 h, 
95%; (m) i. LiCl, pyridine, reflux, 10 h; ii. NaHCO3, MeOH/H2O, reflux, 1 h, 88%.
56
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Two years later, Pan et al. reported the synthesis of five naturally occurring C7-oxidized 
dehydroabietanes (Scheme 7).
60
 Starting from ferruginyl methyl ether (44), oxidation with 
CrO3 in AcOH gave the ketone 45, in 84% yield. In their synthesis plan, compound 45 
served as a common intermediate from which they successfully synthesized the five natural 
abietanes sugiol (8), 5,6-dehydrosugiol (48),
61
 xanthoperol (49),
62
 6α-hydroxysugiol (50)63 
and 6-hydroxy-5,6-dehydrosugiol (52)
64
 in 1–5 steps. 
 
Scheme 7. Pan’s synthesis of sugiol (8), 5,6-dehydrosugiol (48), xanthoperol (49),  
6α-hydroxysugiol (50)  and 6-hydroxy-5,6-dehydrosugiol (52). Reagents and conditions: (a) CrO3 
(1.2 eq), AcOH, rt, 0.5 h 84%; (b) NaSEt, DMF, reflux, 98%; (c) isopropenyl acetate, TsOH, 
reflux, 3 h, 99%; (d) i. mCPBA, CH2Cl2; ii. KI/H2O, Na2S2O3, 0 °C, 93%; (e) K2CO3, MeOH/H2O, 
24 h, air, rt, 74%; (f) TsOH, PhH, reflux, Ar, 85%; (g) NaSEt, DMF, reflux, 98%; (h) NaSEt, DMF, 
reflux, air, 5 h, 92%; (i) NaSEt, DMF, 110 °C, Ar, 90%; (j) O2, t-BuOK/t-BuOH, 1h, 0 °C, 68%; 
(k) NaSEt, DMF, reflux, 91%; (l) BBr3, CH2Cl2, 0 °C, 58%; (m) > 115 °C.
60
 
Ohwada et al. have investigated the activity of dehydroabietic acid derivatives as openers 
of large-conductance voltage- and Ca
2+
-activated K
+
 channels (BK channels) in several 
studies.
22, 23, 65–68 
BK channels play important and specific roles in diverse cellular 
16 
 
functions and many medical conditions such as epilepsy and bladder overactivity are 
involved with the dysregulation of BK channels.
69 
In an early study they showed that the 
introduction of chloro-substituents at positions 12 and 14 in compound 53 lead to a 
significant increase in the BK channel opening activity (Scheme 8).
65 
In the search for even 
more potent BK openers the research group prepared a series of oxime and oxime ether 
derivatives (56 and 57a–57e) starting from 53 (Scheme 8).22 Their synthesis involved the 
7-oxo compound 55 as the key intermediate, which was prepared from methyl  
12,14-dichlorodehydroabietate (54), in 58% yield, through benzylic oxidation with CrO3 in 
AcOH/Ac2O. Treatment of 55 with hydroxylamine hydrochloride in EtOH gave the oxime 
56 which was O-alkylated with different alkyl bromides. Finally, base hydrolysis gave the 
desired oxime ethers 57a–e with a free carboxylic acid. 
 
Scheme 8. Ohwada’s synthesis of dehydroabietic acid derivatives with BK channel opening 
activity. Reagents and conditions: (a) TMSCHN2, MeOH/toluene, rt, 90%; (b) CrO3 (1.1 eq), 
AcOH/Ac2O, 50 °C, 9 h, 58%; (c) NH2OH·HCl/EtOH, pyridine, reflux, 87%; (d) RBr, TBAB,  
1 N KOH, CH2Cl2, 40 °C, 60–89%; (e) KOH, 18-crown-6, MeOH, reflux, 43–85%.
22
 
In a later study, Ohwada et al. prepared a series of oxime ethers starting from methyl 
dehydroabietate 58a–e, methyl 12-bromodehydroabietate 59a–b, and methyl  
11,12,14-trichlorodehydroabietate 60a–b by a similar procedure (Figure 3).23 All of the 
prepared oximes and oxime ethers were tested for their BK channel opening activity. 
Compound 58a proved to be the most potent BK opener with even higher activity than that 
of the known BK opener NS1619.
70
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Figure 3. Dehydroabietic acid derivatives with potential BK channel opening activity and the 
known BK channel opener NS1619.
23, 70
 
In search for new antimicrobial agents Gu et al. prepared a series of novel carbazole 
derivatives from dehydroabietic acid (6) (Scheme 9).
24
 The key intermediate methyl  
7-oxodehydroabietate (17) was prepared in 64% yield by benzylic oxidation with CrO3 in 
AcOH and Ac2O. The Fischer indole reaction of 17 and variously substituted 
phenylhydrazine hydrochlorides in the presence of hydrochloric acid afforded the 
carbazole derivatives 61a–e in moderate to good yields (36–71%). Further 
functionalization at the nitrogen of 61a (R = H) was achieved by N-alkylation with  
1,2-dibromoethane in the presence of TBAB to give compound 62 in 56% yield followed 
by substitution with various aliphatic and aromatic amines to give a second series of novel 
compounds 63a–u, in 18–67% yields (Scheme 9).25 Upon testing the antimicrobial activity 
of these novel derivatives it was found that among the first series, compounds with 
electron withdrawing substituents on the aromatic ring at C-10 (61e) and C-12 (61d, 61f 
and 61m) showed increased activity than their analogs with electron donating substituents. 
Of the N-substituted compounds 63a-u, compound 63j exhibited good antimicrobial 
activity with a broad spectrum against several bacteria and fungi while compound 63r was 
especially efficient against Bacillus subtilis. In another study the anticancer effect in 
hepatocellular carcinoma cells activity of 63i was reported.
71
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Scheme 9. Gu’s synthesis of dehydroabietic acid derivatives with antimicrobial activity. Reagents 
and conditions: (a) i. SOCl2, benzene, reflux, 3 h; ii. MeOH, reflux, 2 h, 92%; (b) CrO3 (1 eq), 
AcOH/Ac2O, 0 °C to rt, 12 h, 64%; (c) ArNHNH2·HCl, HCl, EtOH, reflux, 4h, 36–71%; (d)  
1,2-dibromoethane, TBAB, NaOH, benzene, rt, 12 h, 56%; (e) respective aliphatic or aromatic 
amine, K2CO3, KI, CH3CN, reflux, 8–12 h, 18–67%.
24, 25
 
A procedure involving oxidation of the aromatic abietanes 24 and  
12-acetoxydehydroabietane (64) with tert-butyl chromate was reported by Barnes et al. in 
1988 (Scheme 10).
72
 tert-Butyl chromate was preformed by adding CrO3 to tert-butanol at 
0 °C followed by the addition of carbon tetrachloride at room temperature. The substrate 
was dissolved in CCl4 followed by the addition of AcOH, Ac2O and the tert-butyl 
chromate solution. The two dehydroabietanes showed a significant difference in reactivity. 
19 
 
The oxidation of compound 64 gave 12-acetoxy-7-oxodehydroabietane (65) in 50% yield 
after 1 h of reaction at reflux. When the reaction time was extended to consume the 
substrate 64 the yield for compound 65 was lowered to around 30% due to further attack 
on the initially formed 7-oxo product. This was also the case with substrate 24 and a 
maximum yield of the ketone 25 (53%) was achieved after 67 h of reaction at room 
temperature before complete consumption of the substrate. 
 
Scheme 10. Barnes’ oxidation of dehydroabietane (24) and 12-acetoxydehydroabietane (64) with 
tert-butyl chromate.
72
 
In addition to chromium trioxide, the oxidation of aromatic abietanes has also been 
achieved with other Cr(VI) compounds. In 2006, Alvarez-Manzaneda et al. published the 
syntheses of natural abietanes picealactone A (67)
73
 and picealactone B (68)
73
 (Scheme 
11).
27
 The 7-oxo functionality in these compounds was introduced by benzylic oxidation 
with pyridinium chlorochromate (PCC) in the presence of sodium acetate. The desired 
ketones 17 and 22 were successfully prepared in 73% and 65% yields starting from methyl 
dehydroabietate (16) and methyl 15-hydroxydehydroabietate (66). Further oxidation by 
treatment with a stream of oxygen in the presence of potassium tert-butoxide gave the 
desired picealactones A (67) and B (68) along with the formation of the diosphenols 69 
and 70, respectively. In the case of substrate 22 the reaction gave an inseparable 1:1 
mixture of 68 and 70, but treatment of the mixture with amberlite-A15 or  
N,N’-dicyclohexylcarbodiimide (DCC) in THF yielded picealactone B (68) as the sole 
product. 
20 
 
 
Scheme 11. Alvarez-Manzaneda’s synthesis of picealactones A (67) and B (68). Reagents and 
conditions: a) PCC, NaOAc, CH2Cl2, reflux, 4h, 73% (17), 65% (22); b) O2, t-BuOK, t-BuOH, rt,  
2 h, 96% (67:69 = 1:2), 98% (68:70 = 1:1); c) Amberlyst A-15, THF, 40 °C, 4 h, 95%; d) DCC, 
THF, rt, 90 min, 97%.
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One year later, the same authors reported the synthesis of natural picealactone C (79)
73
 by 
a similar synthetic route (Scheme 12).
74
 This time the benzylic oxidation of precursor 72 
was accomplished by using sodium chromate as the oxidizing agent to give the 7-oxo 
compound 73, in 90% yield. However, treatment of the ketone 73 with O2 and t-BuOK in  
t-BuOH did not give the analogous lactone and diosphenol as was the case in the previous 
study, but instead resulted in the formation of deacetylated compound 74. The oxidation of 
the methyl ether derivative 75 was successful and the product mixture (76 and 77) was 
converted into compound 77 by treatment with DCC. Demethylation and treatment of the 
resulting product mixture with DCC finally gave the desired lactone 79, in 71% yield, from 
compound 77. 
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Scheme 12. Alvarez-Manzaneda’s synthesis of picealactone C (79). Reagents and conditions: (a) 
NaOAc, Ac2O, reflux, 2h, 91%; (b) Na2CrO4 (2 eq), NaOAc, AcOH, benzene, reflux, 18 h, 90%; 
(c) O2, t-BuOK, t-BuOH, rt, 2 h, 95% (d) MeI, K2CO3, acetone, reflux, 4 h, 95%; (e) O2, t-BuOK,  
t-BuOH, rt, 2 h, 95% (76:77 = 1:1); (f) DCC, THF, rt, 30 min (75% from 75); (g) HBr, AcOH,  
40 °C, 1 h, (78:79 = 1:2); (h) DCC, THF, rt, 30 min (71% from 77).
74
 
The benzylic oxidation with Na2CrO4 in the presence of NaOAc was also used to 
accomplish the ring B functionality in the syntheses of natural abietanes sugiol (8) and 
sugikurojin A
 
(84)
75
 by the research groups of Marcos
76
 and Alvarez-Manzaneda,
19
 
respectively (Scheme 13). In the latter example the Δ6 functionality of the target compound 
84 is achieved by reducing the intermediate 7-oxo compound with LiAlH4 at reflux. 
22 
 
 
Scheme 13. Marcos’ and Alvarez-Manzaneda’s syntheses of sugiol (8) and sugikurojin A (84). 
Reagents and conditions: (a) Ac2O, pyridine, 6 h, rt, 98%; (b) Na2CrO4 (3 eq), NaOAc, 
AcOH/Ac2O, 65 °C, 45 min, 77%; (c) K2CO3, MeOH, rt, 96%; (d) Na2CrO4, NaOAc, AcOH/Ac2O, 
70 °C, 3 h, 83%; (e) LiAlH4, THF, rt to reflux, 12 h, 98%.
76, 19
 
 
2.3 Other oxidations 
In addition to the benzylic oxidations discussed above, a few other procedures for 
preparing the C-7 and C-15 oxygenated aromatic abietanes by benzylic C–H oxidation 
have been reported. In an early report, Gigante et al. described the photooxidation of 16 in 
t-BuOH under irradiation with a mercury vapor lamp (Scheme 14).
77
 After 38 h of reaction 
products methyl 7-oxodehydroabietate (17) and compound 23 were isolated in 37% and 
1% yields, respectively, together with the recovery of 47% of unreacted starting material. 
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Scheme 14. Gigante’s photooxidation of methyl dehydroabietate (16) and methyl  
7-oxodehydroabietate (17).
77
 
When compound 17 was used as the starting material under similar reaction conditions for 
73 h, compounds methyl 13-acetyl-7-oxopodocarpa-8,11,13-trien-15-oate (23), methyl  
15-hydroxy-7-oxodehydroabietate (22) and 13-acetyl-2,7-dioxo-podocarpa-8,11,13-trien-
15-oate (85) were obtained in 30%, 21%, and 12% isolated yields, respectively. Prolonging 
the reaction time to 3 weeks gave products 23, 22 and 85 in 34%, 31%, and 4% yields, 
repeatedly, together with six other minor products including ring B lactols. It was also 
found that when using a less polar solvent such as n-hexane almost all of the starting 
material was recovered even after 5 days of reaction. 
In another study, Li and McChesney oxidized methyl dehydroabietate (16) with  
N-bromosuccinimide (NBS) which gave the 15-hydroxy-7-oxo derivative 22, in 79% yield, 
together with the side product 17 (Scheme 15).
78
 The analogous oxidations of 
dehydroabietinol acetate (86) and dehydroabietane (24) gave the 15-hydroxy-7-oxo 
products 87 and 27 in 76% and 79% yield, respectively, along with minor products 88 and 
25. 
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Scheme 15. Li’s and McChesney’s benzylic oxidation of dehydroabietic acid derivatives with 
NBS.
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Glushkov et al. reported the oxidation of ether derivatives 89a–d of dehydroabietic acid 
with KMnO4–MnSO4 in pyridine (Scheme 16).
79
 The 7-oxo products 90a, 90b, 90c and 
90d were obtained in 60%, 52%, 22% and 28% yields, respectively. The ketone 90a was 
further used in a two-step synthesis of the carbazole derivative 92. Treatment of 90a with 
phenylhydrazine in the presence of HCl gave the intermediate 91, in 42% yield, which 
underwent a Fischer reaction to give 92, in 24% yield. 
 
Scheme 16. Glushkov’s benzylic oxidation of dehydroabietic acid derivatives with KMnO4–
MnSO4 in pyridine. Reagents and conditions: (a) KMnO4, MnSO4·H2O, pyridine, 85–90 °C, 6 h, 
22–60%; (b) PhNHNH2, HCl, EtOH, reflux, 12 h, 42%; (c) HCl, AcOH, reflux, 5h, 24%.
79 
Metal porphyrin complexes of different transition metals have been studied as biomimetic 
catalysts for oxidations of various organic substrates.
80
 The metalloporphyrins mimic the 
activity of cytochrome P450, which catalyses hydroxylation reactions of steroids.
81
 The 
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benzylic oxidation of methyl dehydroabietate (16) with hydrogen peroxide catalyzed by 
different manganese (III) porphyrin complexes (95-97) was attempted by Cavaleiro et al. 
in 1996 (Figure 4).
82
 All of the catalysts failed to give methyl 7-oxodehydroabietate (17) in 
high yields and the best result, 11% yield, was obtained with Mn(TDCPP)Cl (95). The 
reaction also produced the isomeric alcohols 93 and 94 in 11% and 21% yields, 
respectively. 
 
Figure 4. Products formed in the oxidation of methyl dehydroabietate (16) with H2O2 catalyzed by 
Mn(III) porphyrin complexes 95–97.82 
Finally, the electrooxidation of methyl dehydroabietate (16) with ruthenium (IV) oxide has 
also been reported.
83
 The reaction gave methyl 7-oxodehydroabietate (17), in 52% yield, 
along with methyl 15-hydroxy-7-oxodehydroabietate (22), in 6% yield. 
2.4 Summary 
The benzylic oxidations of aromatic abietanes have been extensively studied for over half a 
decade. The interest in this type of chemical transformation arises from the fact that 
oxygen functionalities are present on benzylic positions C-7 and C-15 in the structures of 
several natural aromatic abietanes. Furthermore, these functionalities offer opportunities 
for further modification in the synthesis of both naturally occurring abietanes and related 
compounds, and unnatural semisynthetic derivatives. 
Many different procedures for the benzylic oxidation of aromatic abietanes have been 
published in the literature. The vast majority of these procedures involve the use of 
chromium (VI) compounds as oxidants. Although Cr(VI) based compounds are powerful 
reagents in various types of oxidation reactions, there are several disadvantages involved in 
the use of these oxidizing agents. Cr(VI) compounds are highly toxic and they are usually 
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needed in large excess amounts in the oxidation procedures, which leads to the formation 
of large amounts of toxic waste. This makes the procedure atom-economically inefficient 
and renders its cost effectiveness due to waste-removal expenses. Some of the procedures 
rely on molecular oxygen, which use is associated with major safety concerns, while others 
require special equipment and are therefore not generally useful. 
In all cases the initial attack of the oxidant occurs on C-7 rather than C-15 as a result of 
steric impediment. Oxidation at C-15 only occurs when the reaction time is extended or the 
amount of oxidant is increased. The procedures involving Cr(VI) oxidants are 
unsatisfactory in providing the C-15 oxygenated products and only two benzylic oxidation 
procedures are available for preparing these derivatives in good yields. 
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3 Transition metal free benzylic C–H oxidations 
Oxidation of alkyl aromatics into the corresponding alcohols and ketones is an extremely 
important chemical transformation as it converts low-value chemicals into versatile 
building blocks required in the synthesis of various fine chemicals, pharmaceuticals and 
agrochemicals. In addition, such functionalities are present in the structures of diverse 
natural products, including dehydroabietanes. 
Traditional methods for benzylic C–H oxidation involve the use of stoichiometric amounts 
of oxidants, such as permanganate, chromium (VI) oxidants and selenium oxide. These 
oxidants are unattractive due to the large amounts of toxic waste that they form. Much 
effort has been made on the replacement of traditional oxidants with environmentally 
friendly, non-polluting alternatives including molecular oxygen and hydrogen peroxide. O2 
is the ideal oxidant due to its high atom efficiency. The development of procedures for the 
benzylic C–H oxidation with O2, including transition metal free approaches is an active 
research area.
84
 Because the aerobic oxidation of dehydroabietanes is already discussed in 
the previous chapter, the topic will be excluded from this chapter. 
The use of transition metal catalysts is common in modern oxidation procedures and many 
efficient oxidations have been developed.
5
 However, the use of transition metals is 
associated with several drawbacks such as large expenses, high toxicity of several 
transition metals, and the use of non-commercial ligands. Moreover, transition metals are 
usually sensitive to air and moisture and the requirement of an inert reaction media, 
increases the operational difficulty of the procedure. In pharmaceutical chemistry it is 
essential to get products free of any residual metals which can be a difficult task, especially 
in the case of homogenous catalysis. Therefore, the development of transition metal free 
procedures using inexpensive and readily available oxidants and catalysts is highly 
beneficial. In this chapter recent advances in the development of transition metal free 
methods for benzylic oxidations are discussed. 
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3.1 Hypervalent iodine reagents 
Hypervalent refers to a main group element that has formally more than 8 valence 
electrons and therefore breaks the octet rule. Hypervalent iodine reagents have similar 
reactivity as transition metal compounds, but unlike transition metal reagents, hypervalent 
iodine reagents are more environmentally friendly.
85
 Nowadays, many different trivalent 
and pentavalent iodine reagents are commercially available (Figure 5). Hypervalent iodine 
reagents are extremely versatile and have synthetic use in various reactions including 
oxidations, C–C bond forming reactions, aminations, halogenations, fragmentation and 
rearrangement reactions, and coupling reactions. In benzylic oxidation, hypervalent iodine 
has been used both as a stoichiometric oxidant and as a catalyst in combination with other 
oxidants, including t-BuOOH and meta-chloroperoxybenzoic acid (mCPBA),
86
 and 
Oxone
87
. The major drawback of hypervalent iodine reagents is their low solubility in 
organic solvents, but this shortcoming is overcome with the development of more soluble 
reagents.
88
 
 
Figure 5. Some commercially available trivalent and pentavalent iodine reagents.
85
 
The benzylic oxidation with (diacetoxyiodo)benzene (DIB) catalyzed by NaN3 at room 
temperature was reported by Telvekar and Sasane in 2012.
89
 Under these mild reaction 
conditions, various cyclic and acyclic aromatic alkanes 98 gave the product ketones 99 in 
good yields (80–87%), in very short reaction times (Table 2). However, the conditions 
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proved to be unsuitable for oxidizing toluene (98, R
1
 and R
2
 = H) since no reaction 
occurred even after a prolonged reaction time (entry 13). The reaction did not proceed in 
the absence of NaN3 or H2O, and according to the proposed reaction mechanism NaN3 
takes part in the formation of an iodanyl radical which abstracts a benzylic proton and thus 
generates the benzylic radical. The benzylic and azide radicals react with each other to 
form an intermediate aromatic azide compound. Oxygen is introduced to this intermediate 
from the solvent H2O resulting in a benzylic alcohol, which finally oxidizes to the benzylic 
ketone by a second equivalent of DIB. 
Table 2. Benzylic C–H oxidation with DIB catalyzed by NaN3.
89
 
 
Entry Substrate Yield
a
 
(%) 
Entry Substrate Yielda 
(%) 
1 R
1
 = Ph, R
2
 = H 85 8 R
1
 = Me, R
2
 = H 85 
2 9H-Fluorene 87 9 R
1
 = i-Pr, R
2
 = H 84 
3 Tetrahydronaphthalene 85 10 R
1
 = Et, R
2
 = H 85 
4 Indane 84 11 R
1
 = Me, R
2
 = OMe 85 
5 9H-Xanthene 80 12 R
1
 = Me, R
2
 = CO2Et 85 
6 Anthracen-9(10H)-one 80 13
b
 R
1
 = H, R
2
 = H - 
7 1-Ethylnaphthalene 85    
a
 Isolated yield. 
b
 Reaction time 120 min. 
The fifth principle of green chemistry seeks to avoid the use of innocuous solvents and 
auxiliaries.
90
 Many organic solvents are considered hazardous due to their high volatility, 
toxicity and/or flammability and the development of processes using alternative, “greener” 
solvents or even solvent-free conditions is desirable. Therefore, Kita et al. developed a 
benzylic C–H oxidation using water-soluble iodosobenzene as the oxidizing agent in 
combination with KBr and the heterogeneous Brønsted acid catalyst montmorillonite-K10 
(M-K10), in aqueous phase, avoiding the use of organic solvents.
91
 According to the 
proposed mechanism the reaction proceeded with initial benzylic bromination of 98 
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followed by hydrolysis and finally oxidation of the benzylic alcohol. The product ketones 
99 were obtained in moderate to excellent yields with no observation of ring brominated 
products (Table 3). The present reaction conditions tolerated different functionalities 
including ester, carboxylic acid and sulfide (entries 5, 8 and 11). Although green, the use 
of H2O as solvent is associated with limited substrate compatibility due to low solubility. 
Table 3. Benzylic C–H oxidation with iodosobenzene/KBr catalyzed by M-K10 in aqueous 
phase.
91
 
 
Entry Substrate Yield
a
 
(%) 
Entry Substrate Yield
a
 
(%) 
1 R
1
 = Me, R
2
 = Br 72 8 R
1
 = Me, R
2
 = CO2H 43 
2 R
1
 = Et, R
2
 = H 70 9
b,c
 9H-Xanthene 93 
3 Indane 72 10 Anthracen-9(10H)-one 83 
4 Tetrahydronaphthalene 82 11
b,d
 9H-Thioxanthene 68 
5 Tetrahydronaphthalen-1-
yl acetate 
55 12 
13 
9H-Fluorene 
R
1
 = Ph, R
2
 = H 
57 
87 
6 R
1
 = cyclopropyl, R
2
 = H 68 14 R
1
 = Pyridin-4-yl, R
2
 = H 68 
7 R
1
 = Me, R
2
 = Me 59    
a
 Isolated yield.
 
b
 Reaction performed at rt.   
c
 Reaction time 3h. 
d
 Reaction performed in the absence of M-K10. Reaction time 8 h. 
In 2001 Nicolaou et al. reported the benzylic oxidation of various alkyl aromatics 98 to 
corresponding aldehydes and ketones 99 using 2-iodobenzoic acid (IBX) in 
fluorobenzene/DMSO (Table 4).
92
 Oxidation of heteroaromatic substrates 98 required a 
longer and a higher reaction time and temperature, respectively, to give the desired 
products 99 in moderate yields (entries 14 and 15). Different substituted toluenes  
(98, R
1
 = H) were oxidized to corresponding aldehydes (99, R
1
 = H) successfully without 
overoxidation to benzoic acids. However, toluenes with electron withdrawing substituents 
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failed to react (entries 17 and 18). In substrates with two benzylic methylene or methyl 
groups, only one position was oxidized to carbonyl level (entries 8, 10, 11 and 14). In the 
previous examples the oxygen atom in the product ketone 99 originated from H2O. In this 
case, dry solvents were used and the oxygen is believed to originate from IBX itself.
93
   
Table 4. Benzylic C–H oxidation with IBX in fluorobenzene/DMSO.92 
 
Entry Substrate Conditions Isolated yield (%) 
1 R
1
 = H, R
2
 = H 3.0 eq, 12 h, 85 °C 85 
2 R
1
 = H, R
2
 = 4-t-Bu 3.0 eq, 8 h, 80 °C 95 
3 R
1
 = H, R
2
 = 2-Ph 3.0 eq, 24 h, 90 °C 78 
4 R
1
 = H, R
2
 = 3-I 4.0 eq, 16 h, 85 °C 72 
5 R
1
 = H, R
2
 = 4-Br 3.0 eq, 16 h, 80 °C 73 
6 R
1
 = H, R
2
 = 3,4-di-OMe 3.0 eq, 5 h, 75 °C 80 
7 R
1
 = n-Pr, R
2
 = H 3.0 eq, 8 h, 80 °C 72 
8 Tetrahydronaphthalene 3.0 eq, 12 h, 80 °C 70 
9 2-Methylnaphthalene 3.0 eq, 20 h, 80 °C 90 
10 R
1
 = H, R
2
 = 2-Me 3.0 eq, 16 h, 85 °C 82 
11 R
1
 = H, R
2
 = 3-Me 3.0 eq, 16 h, 85 °C 85 
12 R
1
 = H, R
2
 = 4-O(CH2)3CHCH2 3.0 eq, 8 h, 80 °C 88 
13 R
1
 = H, R
2
 = 2-OCH2CHCH2 3.0 eq, 12 h, 80 °C 80 
14 5,6,7,8-Tetrahydroisoquinoline 3.0 eq, 24 h, 85 °C 70 
15 R
1
 = H, R
2
 = 4-Pyridin-4-yl 4.0 eq, 36 h, 90 °C 52 
16 R
1
 = H, R
2
 = NHCO2CH2CHCH2 3.0 eq, 12 h, 85 °C 60 
17 R
1
 = H, R
2
 = 4-CN 3.0 eq, 24 h, 90 °C - 
18 R
1
 = H, R
2
 = 4-OMe 3.0 eq, 24 h, 90 °C - 
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3.2 Peroxide and peroxy acid oxidants 
Hydrogen peroxide is an attractive terminal oxidant because it is cheap, readily available 
and only produces water as the waste product. The major drawback with using H2O2 is that 
large excess amounts are usually needed because it decomposes easily. Transition metal 
free benzylic oxidation with H2O2 is rare and so far only one procedure has been 
reported.
94
 In this procedure, various aryl alkanes 98 were oxidized with hydrogen 
peroxide in combination with hydrogen bromide under mild reaction conditions (Table 5). 
The reaction proceeded by initial bromination of 98 at the benzylic methylene, followed by 
hydrolysis and finally, oxidation to the aryl ketone 99. The procedure was unsuccessful for 
the oxidation of aromatic substrates 98 with a long chain alkyl substituent (entries 2, 3 and 
12) and a significant amount of the brominated product 100 was formed. This result is 
explained by incomplete bromination in the initial step or by very slow hydrolysis of the 
brominated intermediate due to steric reasons. When an electron-rich aryl alkane 98 was 
used as the substrate, electrophilic aromatic substitution with ring bromination (product 
101) became a competing reaction to the radical bromination at the benzylic position 
(entries 14 and 16). The evident shortcoming of this reaction is the low selectivity. In order 
for this procedure to be of general usefulness in the synthesis of various aromatic ketones 
99, further development is required. 
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Table 5. Benzylic C–H oxidation with H2O2 in combination with HBr.
94
 
 
Entry Substrate Time (h) 99:100
a
 Yield (%)
b
 
1 R
1
 = Me, R
2
 = H 12 84:16 75 
2 R
1
 = n-Pr, R
2
 = H 20 50:50 45
c
 
3 R
1
 = n-Pentyl, R
2
 = H 30 30:70 30
c
 
4 R
1
 = n-Pentyl, R
2
 = 4-NO2 28 90:10 70 
5 R
1
 = Me, R
2
 = 4-Ph 12 100:0 85 
6 R
1
 = Ph, R
2
 = H 12 100:0 91 
7 Tetrahydronaphthalene 20 100:0 90
c
 
8 R
1
 = (CH2)2OH, R
2
 = H 12 100:0 72 
9 R
1
 = CH2OAc, R
2
 = H 24 100:0 72 
10 R
1
 = (CH2)2OAc, R
2
 = H 25 100:0 88 
11 R
1
 = (CH2)3OAc, R
2
 = H 30 100:0 88 
12 R
1
 = (CH2)4OAc, R
2
 = H 30 45:55 40 
13 R
1
 = (CH2)3OBz, R
2
 = H 20 90:10 71 
14 R
1
 = Me, R
2
 = 4-OH 3 - 76
c
 (101) 
15 R
1
 = Me, R
2
 = 4-OAc 8 - 72 (100) 
16 R
1
 = Me, R
2
 = 4-NHAc 3 - 71 (101) 
17 R
1
 = Me, R
2
 = 3-NO2-4-NHAc 15 - 70 (100) 
a
 Ratio determined from 
1
H NMR spectrum. 
b
 Isolated yield. 
c
 Yields based on starting material recovery. 
tert-Butyl hydroperoxide is an inexpensive and commonly used oxidant available 
commercially as both 70–90% aqueous solutions and anhydrous hydrocarbon solutions. 
Being thermally more stable than H2O2, t-BuOOH has found uses in numerous oxidation 
reactions in combination with catalysts or other stoichiometric oxidants, the most famous 
reaction being the asymmetric Sharpless epoxidation. Recently, the use of t-BuOOH in 
transition metal free benzylic C–H oxidations has also been reported. 
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A stoichiometric benzylic C–H oxidation by sodium bismuthate reported in 199895 inspired 
Barrett and his coworkers to develop a bismuth-catalyzed method using t-BuOOH as the 
oxidant.
96
 Although bismuth is a heavy metal it is considered as a “green element” due to 
its low toxicity.
97
 The bismuth(0) precatalyst was generated from Bi2O3 by reduction with 
NaBH4. The oxidation provided the aromatic ketones 99 from the corresponding parent 
alkylarenes 98 in moderate to excellent yields (Table 6). Substrates containing diaryl 
methylenes (entries 2–6 and 13) underwent oxidation in higher yields as well as an arene 
(98, R
1
 = Me, R
2
 = 4-OMe) with an electron donating substituent (entry 9). Isochromane 
was selectively oxidized to the corresponding lactone 99 (entry 13). Oxidation of an 
electron deficient alkylarene (98, R
1
 = Me, R
2
 = 2-NO2) required a longer reaction time 
(entry 12). The present reaction conditions were also efficient in oxidizing some 
methylarenes into the corresponding aromatic carboxylic acids, although changing the 
catalyst to bismuth triflate gave better results with a larger selection of substrates. 
Table 6. Bismuth-catalyzed benzylic C–H oxidation with t-BuOOH.96 
 
Entry Substrate Yield 
(%) 
Entry Substrate Yield 
(%) 
1 Tetrahydronaphthalene 77 10 R
1
 = Me, R
2
 = 3-Me 54 
2 R
1
 = Ph, R
2
 = H 95 11 R
1
 = Me, R
2
 = 3-Br 71 
3 9H-Fluorene 91 12
a
 R
1
 = Me, R
2
 = 2-NO2 68 
4 11H-Benzo[b]fluorene 99 13 Isochromane 91 
5 10,11-Dihydro-5H-
dibenzo[a,d][7]annulene 
70 14 
15 
Acetyltetrahydroquinoline 
3-Butylpyridine 
56 
48 
6 4a,9a-Dihydro-9H-xanthene 88 16 3-Ethylpyridine 74 
7 9,10-Dihydrophenanthrene 50 17 2-Ethylthiophene 72 
8 Indane 65 18 R
1
 = cyclopropyl, R
2
 = H 72 
9 R
1
 = Me, R
2
 = 4-OMe 93    
a
 Reaction time 36 h. 
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Reddy et al. reported a KI-catalyzed benzylic C–H oxidation with t-BuOOH in 
acetonitrile.
98
 Various simple aromatic alkanes 98 were successfully oxidized to the 
corresponding ketones 99, in moderate to excellent yields (Table 7). Indane required a 
much longer reaction time while the yield remained comparatively low and GC-MS 
analysis revealed the formation of 1-indanol as a side product (entry 3). The oxidation of 
9,10-dihydroanthracene gave the diketone anthracene-9,10-dienone with both benzylic 
methylenes oxidized to carbonyl level (entry 5). Oxidation of N-heterocyclic substrates 
indoline, tetrahydroisoquinoline and tetrahydroquinoline led to aromatization of the 
heterocyclic ring instead of benzylic oxidation. The developed procedure was also used in 
the final step in the synthesis of benzo[d][1,3]oxazin-4-ones. 
Table 7. Mild benzylic C–H oxidation with KI/t-BuOOH.98 
 
Entry Substrate Time (h) Isolated yield (%) 
1 R
1
 = Me 24 82 
2 R
1
 = Ph 21 78 
3 Indane 48 42 
4 Tetrahydronaphthalene 24 35 
5
a
 9,10-Dihydroanthracene 11 97
b
 
6 Tetrahydroisoquinoline 24 38
c
 
7 1,3-Dihydroisobenzofuran 7 90 
8 Isochromane 10 95
d
 
9 9H-Xanthene 10 98 
10 9H-Fluorene 9 96 
11 2-Bromo-9H-fluorene 15 82 
12 9H-Fluoren-2-yl acetate 30 65 
a
 Reaction performed with 6 eq of t-BuOOH. 
b
 Anthracene-9,10-dienone.  
c
 6,7-dihydroisoquinolin-8(5H)-one.    
d
 Isochroman-1-one. 
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In 2009 two novel methods for the benzylic oxidation were reported using aqueous  
t-BuOOH in otherwise solvent free conditions (Scheme 17).
99, 100
 Lee and his coworkers 
discovered that the oxidation of alkyl aromatics 98 with t-BuOOH under microwave 
irradiation was very efficient, yielding the product ketones 99 in moderate to excellent 
yields (53–98%), and very short reaction times (10–30 min).99 The microwave assisted 
oxidation of toluenes and xylenes 98 into corresponding aromatic mono- and dicarboxylic 
acids (102 and 103) was also demonstrated, but these products were obtained in lower 
yields. In the case of toluenes (98, R
1
 = H), the ionic liquid 1-butyl-3-mehtylimidazolium 
tetrafluoroborate was added to achieve enhanced reactivity. 
 
Scheme 17. Lee’s and Wang’s t-BuOOH-mediated benzylic C–H oxidations under solvent-free 
conditions.
99, 100
 
The other solvent-free t-BuOOH-mediated benzylic oxidation developed by Wang et al. 
involved the use of iodine and pyridine as the catalytic system (Scheme 17).
100
 The product 
ketones 99 were obtained in moderate to excellent yields (42–99%). Surprisingly, the 
presence of an electron withdrawing substituent on the substrate 98 favored the reactivity 
and gave the product 99 in a higher yield than corresponding substrates 98 with electron 
donating substituents under identical reaction conditions. 
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In a recent publication, Yan et al. describe a method for benzylic oxidation catalyzed by 
(diacetoxyiodo)benzene (DIB) in combination with stoichiometric amounts of t-BuOOH 
and mCPBA in 2,2,2-trifluoroethanol (TFE).
86
 In the case of the monosubstituted 
alkylarenes (98, R
2
 = H), increasing size and branching of the alkyl substituent led to 
poorer yields due to steric hindrance (entries 6–9 in Table 8). Surprisingly, the oxidation of 
the electron rich arene 4-ethylanisole (entry 10) gave the product ketone (99, R
1
 = Me, R
2
 
= H) in lower yield than ethylbenzene (entry 6). The current method failed to oxidize an 
electron deficient arene (entry 11) and diaryl compounds (entries 12 and 13) efficiently. 
Table 8. Benzylic C–H oxidation with t-BuOOH/mCPBA catalyzed by DIB.86 
 
Entry Substrate Yield
a
 
(%) 
Entry Substrate Yield
a
 
(%) 
1 Indane 92 8 R
1
 = n-Pr, R
2
 = H 47 
2 Tetrahydronaphthalene 95 9 R
1
 = i-Pr, R
2
 = H 40 
3 9H-Fluorene 86
b
 10 R
1
 = Me, R
2
 = OMe 63 
4 9H-Xanthene 99 11 R
1
 = Me, R
2
 = NO2 11 
5 Anthracen-9(10H)-one 97 12 R
1
 = Ph, R
2
 = H 38
b
 
6 R
1
 = Me, R
2
 = H 93 13 R
1
 = Pyridin-4-yl, R
2
 = NO2 11
b
 
7 R
1
 = Et, R
2
 = H 62    
a
 Isolated yield. 
b
 Reaction performed with EtOAc as the solvent. 
Another procedure using a hypervalent iodine reagent in combination with t-BuOOH was 
reported by Catir and Kilic in 2010.
101
 The stoichiometric oxidation with 
bis(trifluoroacetoxyiodo)benzene (BTI) and t-BuOOH in the presence of NaHCO3 was 
optimized for tetrahydronaphthalene and the product α-tetralone was obtained, in 75% 
yield. However, the procedure showed narrow substrate compatibility and sterically 
hindered aromatic alkanes gave the corresponding ketones in poor yields. 
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3.3 Oxone 
Oxone (2 KHSO5·KHSO4·K2SO4) is a non-toxic, cheap and stable oxidant that has proven 
to be efficient in the oxidation of various organic substrates including alcohols, amines, 
carbonyl compounds, sulfides and in the epoxidation of alkenes.
102
 More recently, both 
Yin et al.
103
 and Moriyama et al.
104
 reported the benzylic oxidation of simple alkyl 
aromatics 98 with Oxone in combination with potassium bromide. Yin’s group found that a 
solvent system of acetonitrile and water gave the best results and the oxidation proceeded 
smoothly for various substrates (98) (Table 9). However for indane (entry 12) only a 
moderate yield of the aromatic ketone 99 was obtained and in the case of toluene (entry 13) 
and 1-ethyl-4-nitroethylbenzene (entry 14) only the brominated product (100, R
1
 = Me, R 
= NO2) was obtained. With an electron-rich substrate (entry 15) ring bromination occurred 
instead of benzylic oxidation. Mechanistic studies with 
18
O-labeled water revealed that the 
oxygen present in the product originated from the solvent water. 
Table 9. Benzylic C–H oxidation with Oxone in combination with KBr.103 
 
Entry Substrate Yield
a
 
(%) 
Entry Substrate Yield
a
 
(%) 
1 R
1
 = i-Pr, R
2
 = H 81 8 R
1
 = Et, R
2
 = H 90 
2 R
1
 = Me, R
2
 = H 87 9 R
1
 = Me, R
2
 = Br 98 
3 R
1
 = Ph, R
2
 = H 99 10 R
1
 = n-Pr, R
2
 = H 78 
4 R
1
 = Me, R
2
 = Et 94 11 Tetrahydronaphthalene 71 
5 Isochroman 94 12 Indane 47 
6 1,3-Dihydroiso- 94 13 
14 
15 
R
1
 = H, R
2
 = H 
R
1
 = Me, R
2
 = NO2 
R
1
 = Me, R
2
 = OMe 
88 (100) 
94 (100) 
95 (101) 
 benzofuran  
7 R
1
 = Me, R
2
 = Ac 94 
a
 Yields based on GC analysis. 
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Moriyama et al. described both a thermal (Method A) and a photochemical (Method B) 
method for the benzylic C–H oxidation in their publication.104 The product ketones 99 
were obtained in good to excellent yields (75– >99%) (Table 10). Both methods showed 
good functional group tolerance for functionalities such as ester (entries 9, 10, 16, 19 and 
21), sulfonyl (entry 11), nitro (entries 12 and 21), nitrile (entries 13 and 15), and imide 
(entry 14). Again, when a substrate containing a strongly electron-donating substituent, 
ring bromination occurred but this time in combination with benzylic oxidation and 1-(3-
bromo-4-methoxyphenyl)ethan-1-one was obtained in 93% yield starting from 1-ethyl-4-
methoxybenzene (entry 18). The oxidation of para-substituted ethylbenzenes 98 (entries 
1–3) and alkylbenzenes 98 bearing functional groups (entries 9–14) was successful only 
under Method A conditions, since the oxidation of these substrates under Method B 
conditions yielded α-bromoketones as by-products. In addition, the ketone products 99 
could not be obtained from alkyl aromatics 98 containing electron-withdrawing 
substituents with Method A and only bromination at the benzylic methylene occurred. 
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Table 10. Benzylic C–H oxidation under thermal (Method A) and photochemical conditions 
(Method B) with Oxone in the presence of KBr.
104
 
 
Entry Method Substrate (A) Isolated yield (%) 
1 A R
1
 = Me, R
2
 = 4-Br 96 
2 A R
1
 = Me, R
2
 = 4-t-Bu 83 
3
a
 A R
1
 = Me, R
2
 = 4-OAc > 99 
4
b
 A R
1
 = H, R
2
 = 4-n-Pr 86 
5
b
 A R
1
 = H, R
2
 = 4-n-Heptyl 87 
6 A R
1
 = Me, R
2
 = 4-i-Pr 90 
7
b
 A R
1
 = Ph, R
2
 = H > 99 
8
b
 A R
1
 = Ph, R
2
 = 4-CF3 > 99 
9 A R
1
 = (CH2)2OAc, R
2
 = H 82 
10 A R
1
 = (CH2)2CO2Me, R
2
 = H 85 
11
c
 A R
1
 = (CH2)3SO2Ph, R
2
 = H 90 
12 A R
1
 = (CH2)3NO2, R
2
 = H 88 
13 A R
1
 = (CH2)3CN, R
2
 = H 75 
14
b
 A N-(3-Benzoylpropyl)-phthalimide 99 
15 B R
1
 = Me, R
2
 = 4-CN 98 
16 B R
1
 = Me, R
2
 = 4-CO2Me 91 
17 B R
1
 = Me, R
2
 = 4-Cl 90 
18
d
 B R
1
 = Me, R
2
 = 4-OMe 93
e
 
19
f
 B R
1
 = CO2Me, R
2
 = H 93 
20 B R
1
 = (CH2)2Cl, R
2
 = H 97 
21
f
 B R
1
 = (CH2)3OAc, R
2
 = 4-NO2 86 
a
 1.2 eq of KBr used.  
d
 2.5 eq of KBr and 2.5 eq of Oxone used. 
b
 Reaction at rt.  
e
 Ring bromination. 
c
 Reaction at 40 °C.  
f
 2.0 eq of KBr and 2.0 eq of Oxone used. 
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A benzylic C–H oxidation with Oxone catalyzed by 2-iodoxybenzenesulfonic acid (IBS) 
generated in situ from sodium 2-iodobenzosulfonate (104), in the presence of phase-
transfer catalyst n-Bu4NHSO4, in anhydrous acetonitrile, was reported by Zhang et al. in 
2011.
87
 The procedure was sufficient for oxidation of various cyclic and acyclic alkyl 
aromatics 98 and the product ketones 99 were obtained in moderate to good yields (Table 
11). Several substrates gave also benzoic acids 102 as side products as a result of 
overoxidation (entries 1, 6–8 and 10). 
Table 11. Benzylic C-H oxidation with Oxone catalyzed by IBS under phase-transfer conditions.
87
 
 
Entry Substrate Time (h) Yield (%) 
   99 102 
1 R
1
 = Ph, R
2
 = H 11 73 17 
2 Fluorene 10 93 - 
3 1,1-Dimethylindane 5 81 - 
4 Indane 5 60 - 
5 Tetrahydronaphthalene 4 52
a
 - 
6 R
1
 = CH3, R
2
 = H 6 50
b
 38 
7 R
1
 = CH3, R
2
 = Br 6 52 37 
8 R
1
 = CH3, R
2
 = OMe 5 72 22 
9 R
1
 = CH3, R
2
 = CO2H 12 79 - 
10
c
 R
1
 = CH3, R
2
 = NO2 24 70 24 
11 9(10H)-Anthracenone 12 90 - 
12 Tetrahydronaphthalen-1-yl acetate 12 71 - 
13 1,3-Dihydroisobenzofuran 5 80 - 
a
 1,4-Naphtoquinone (11%) and phthalic acid (4%) were also obtained. 
b
 Yield based on GC analysis. 
c
 0.1 eq of 104 and 6 eq of Oxone used. 
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3.4 Miscellaneous oxidants 
In addition to all the transition metal free benzylic oxidations described above, a couple 
more methods have been developed. Shabaani and his coworkers have studied the benzylic 
C–H oxidation using sodium bromate.105–107 In an early report from 2002 the oxidation was 
performed with a stoichiometric amount of NaBrO3 in combination with either ammonium 
chloride or tetrabutylammonium sulfate.
105
 However, the yields remained low (15–70%) 
and an improved method using a recyclable solid ion exchange catalyst under solvent-free 
conditions at room temperature was reported one year later (Table 12, Method A).
106
 The 
aromatic ketones 98 were obtained in higher yields (70–95%) and the oxidizing conditions 
were especially efficient when a lactone was formed as the product (entries 9 and 10). 
 
Table 12. Solvent-free oxidation with NaBrO3/ion exchange resin (Method A) or 
NaBrO3/[BMIM]Br (Method B).
106, 107
 
Entry Substrate Method Time (h) Isolated yield (%) 
1 
R
1
 = Me 
A 24 80 
2 B 10 75 
3 
R
1
 = Ph 
A 10 85 
4 B 17 79 
5
a
 
Indane 
A 5 94 
6 B 15 83 
7 
Tetrahydronaphthalene 
A 6 80 
8 B 10 85 
9 
1,3-Dihydroisobenzofuran 
A 2.5 95 
10 B 15 84 
11 Isochroman A 3 95 
12 Xanthene B 9 90 
a
 Reaction performed at 116 °C. 
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Later, Shabaani’s group presented one further NaBrO3-mediated benzylic oxidation in 1-
butyl-3-methylimidazolium bromide ([BMIM]Br) (Table 12, Method B).
107
 The reaction 
proceeded smoothly at 70 °C giving the product ketones in somewhat lower yields 
compared to the ion exchange resin catalyzed reaction. The ionic liquid [BMIM]Br could 
be recycled and used in subsequent reactions without any reduction in reactivity. 
Sodium chlorite is used as a bleaching agent in paper and textile industries and as an 
oxidative disinfectant in water treatment.
108 Recently, this cheap and very stable oxidant 
has found various applications in organic synthesis. In 2007 Silvestre and Salvador 
reported both a stoichiometric and catalytic NaClO2-mediated procedure for benzylic and 
allylic oxidation (Table 13).
109
 The stoichiometric procedure (Method A) involved the use 
of t-BuOOH while NHPI was used as the catalyst in the other procedure (Method B). The 
reaction proceeded smoothly under both reaction conditions resulting in the aromatic 
ketones 99 in similar yields. However, the reaction times were significantly shorter using 
the catalytic conditions (entries 2, 4, 6 and 7). Mechanistic studies revealed the presence of 
a ClO2 radical under both reaction conditions and the presence of a radical scavenger 
(butylated hydroxytoluene, BHT) hindered the reaction. Thus, the NaClO2-mediated 
oxidations occur via a free radical mechanism. 
Table 13. NaClO2-mediated benzylic C–H oxidation.
109
 
 
Entry Substrate  Method Time (h) Isolated yield (%) 
1 
9H-Xanthene 
A 40 89 
2 B 2 91 
3 
9H-Fluorene 
A 64 90 
4 B 1 90 
5 
R
1
 = Ph 
A 52 86 
6 B 6 89 
7 Isochromane B 18 75 
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3.5 Summary 
In recent years, the growing concern on the safety of chemicals and their environmental 
impact has led to an increasing demand on the development of alternative approaches in 
chemical syntheses using sustainable methods and technologies. Although many transition 
metal reagents efficiently bring about various chemical transformations, their use is 
disadvantageous because these reagents are often expensive, highly toxic and very 
sensitive to air and moisture. Thus, the development of transition metal free approaches is 
highly beneficial. 
Direct benzylic C–H oxidation is an important chemical transformation and transition 
metal free approaches have been studied extensively during recent years. Numerous 
procedures, both catalytic and stoichiometric, using various oxidants including hypervalent 
iodine reagents, peroxides and peroxy acids, Oxone, sodium bromate and sodium chlorite 
have been developed. Many of these oxidations proceed smoothly under mild reaction 
conditions giving the aromatic ketones, aldehydes and carboxylic acids in high yields and 
short reaction times.  
In all of the studies discussed above, the oxidations of only very simple substrates have 
been investigated. In many cases, as soon as the size of the alkyl substituent grows, 
problems in reactivity and selectivity emerge due to steric hindrance. The procedures 
involving initial bromination on the benzylic position followed by hydrolysis and oxidation 
are associated with the formation of side products due to incomplete hydrolysis of the 
reaction intermediate or ring bromination by the competing SEAr reaction. The major 
drawback associated with hypervalent iodine reagents is their low solubility in organic 
solvents. The oxidations in water or solvent free conditions are not suitable for organic 
substrates of increasing complexity. 
Nevertheless the results from the transition metal free benzylic C–H oxidations are 
encouraging. What remains to be seen is whether these procedures will be generally useful 
in the synthesis of various organic compounds with increasing structural complexity, 
including natural products and their derivatives. 
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II Experimental part 
4 Aim of the study 
The oxidized derivatives of dehydroabietanes are interesting, not only for their biological 
activities but also for their use as intermediates in further functionalisation of the 
dehydroabietane core, as seen in the literature research. Several procedures for the benzylic 
oxidation of dehydroabietanes have been published with most of these procedures relying 
on toxic chromium (VI) compounds as oxidants, which makes them unappealing from an 
environmental aspect. The production of high amounts of toxic waste leads to additional 
expenses in waste removal and renders the cost-efficiency of the procedure. Other 
procedures suffer from poor yields, and/or harsh reaction conditions, or require specific 
equipment, and are thus not convenient as general synthetic methods. In the case of aerobic 
oxidations the use of molecular oxygen is always associated with major safety concerns. 
In this Master’s thesis, the benzylic oxidations of dehydroabietanes with non-polluting and 
cheap oxidants are studied with the aim to find a novel, cost-efficient and environmentally 
friendly oxidation procedure that is easy to operate. On basis of the literature search on 
transition-metal free benzylic C–H oxidations, sodium chlorite NaClO2 was chosen as one 
of the oxidants to be investigated because it is cheap, readily available and environmentally 
friendly. The procedure developed by Silvestre and Salvador afforded the simple aromatic 
ketones in good yields and under mild conditions
109
 and we were curious to see if this 
procedure would be efficient for the benzylic oxidation of aromatic abietanes as well. Both 
the stoichiometric oxidation using t-BuOOH, and the catalytic version using NHPI 
mediated by NaClO2 were investigated. 
In addition, the use of Oxone as the terminal oxidant was studied, because it is well known 
in the literature. Oxone has grown much attention recently as a mild, cheap and 
environmentally friendly oxidant and it has proved to be useful in the oxidations of various 
substrates, including alkylarenes.
87, 103, 104
 Finally, to compare the successfulness of these 
transition metal free oxidations the benzylic oxidation with CrO3 was also performed. 
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After finding the most promising procedure on preliminary testing, the goal was to further 
optimize this procedure for our substrates by examination of different reaction times, 
temperatures and reagent mole ratios. With the optimized conditions in hand, the generality 
of the procedure was to be explored next, using different dehydroabietic acid derivatives as 
substrates. In order to obtain more easily comparable results, substrates with modification 
only at C-18 were chosen. 
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5 Results and discussion 
For the preliminary experiments, methyl dehydroabietate (16) was chosen as the model 
substrate because it is easy to prepare and its oxidation is well reported in the literature. 
Compound 16 was synthesized successfully in 97% from commercial dehydroabietic acid 
(6) by a base-catalyzed esterification with methyl iodide according to a reported procedure 
(Scheme 18).
110
 
 
Scheme 18. Synthesis of methyl dehydroabietate (16). 
The benzylic oxidations of substrate 16 with NaClO2/t-BuOOH
109
 (Method A), 
NHPI/NaClO2
109
 (Method B) and KBr/Oxone
103
 (Method C) according to reported 
procedures were investigated. Oxidation with CrO3 in EtOAc/AcOH (Method D) was also 
performed and the results from all these reactions are collected in Table 14. The oxidation 
of 16 with sodium chlorite in the presence of tert-butyl hydroperoxide gave a product 
mixture and TLC analysis revealed six different product spots. After purification of the 
mixture with flash column chromatography (FCC) methyl 7-oxodehydroabietate (17) was 
obtained in 43% yield along with minor products methyl 15-hydroperoxy-7-
oxodehydroabietate (20) and 15-hydroxy-7-oxodehydroabietate (22) in 10% and 2% 
yields, respectively. Traces of other products could be seen as small impurities in the 
1
H 
and 
13
C NMR spectra of the isolated products 17, 20 and 22. Compounds 20 and 22 are 
easily distinguished from each other due to the large difference in the chemical shifts of C-
15 in the 
13
C NMR spectrum: for compound 20 the chemical shift of C-15 is 83.8 ppm and 
for compound 22 the corresponding value is 72.4 ppm. The structures were further 
confirmed by HRMS analysis. The found molecular ion [M+H]
+
 peaks for compounds 20 
and 22 are 361.2011 and 345.2068, respectively. The difference in these values arises from 
one more oxygen atom present in compound 20 than in 22. 
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Table 14. Screening of reaction conditions for the benzylic C–H oxidation of methyl 
dehydroabietate (16). .
 
Procedure Yields (%) Recovery of 16 (%) 
 17 20 22 23 
Method A 43 10 2 - - 
Method B 24 3 4 - 13 
Method C - - - - 60 
Method D 47 - - 6 - 
 
Although Silvestre and Salvador indicated that the NHPI-catalyzed oxidation with NaClO2 
(Method B) was more efficient in providing the aromatic ketones with shorter reaction 
times, we obtained the opposite results. TLC monitoring of the two reactions after one day 
revealed that the substrate was consumed to a lesser extent under the catalytic conditions 
than the oxidation under Method A conditions. The reaction with Method B conditions 
resulted in recovery of the starting material (13%) along with reduced yields of the 
oxygenated products 17 (24%), 20 (3%) and 22 (4%). 
Oxidation of 16 with Oxone in the presence of KBr (Method C) was unsuccessful. Even 
after 5 days of reaction and an increase in the reaction temperature to 65 °C, TLC 
monitoring revealed no signs of reactivity, and only impure starting material (60%) was 
recovered. These conditions were clearly not strong enough to oxidize our substrate, which 
benzylic positions are far less activated than those of the simple alkylarenes investigated 
by Yin et al.
103
 Oxidation with CrO3 (Method D) gave methyl 7-oxo-dehydroabietate (17), 
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in 47% yield, along with the formation of 13-acetyl-7-oxopodocarpa-8,11,13-trien-15-oate 
(23), in 6% yield. One shortcoming of this procedure is the inconvenient extractive work-
up in which an emulsion forms easily, making it difficult to separate the organic and 
aqueous phases. 
The results from the initial experiments suggested that a novel transition metal free 
benzylic C–H oxidation of dehydroabietanes could be developed according to Method A 
conditions. Thus, we set out to optimize the reaction conditions for our model substrate 16. 
The formation of the minor products 20 and 22 made us question whether the ratio of the 
differently oxygenated products could be manipulated by altering the reaction conditions. 
Several experiments were performed with different reaction times, temperatures, and 
reagent mole ratios. In this procedure, the remaining oxidant is destroyed by stirring the 
reaction mixture in a saturated aqueous Na2SO3 solution. Different durations of the Na2SO3 
treatment were investigated since it was unclear to us whether or not these conditions were 
strong enough to reduce the hydroperoxide functionality in product 20. The results from all 
the experiments are collected in Table 15. 
Table 15. Optimization of reaction conditions for methyl dehydroabietate (16). 
Entry Temp. 
(°C) 
Time 
(d) 
NaClO2 
(eq) 
Na2SO3 
(h) 
Yields (%)
a
 Ratio 
17 20 22 23 17:20:22:23 
1 60 1 1.2 20 43 10 2 - 78:18:2:0 
2 60 1 1.2 3 38 12 - - 76:24:0:0 
3
b
 40 3 1.2 20 6 14 1 - 28:67:5:0 
4 60 3 1.2 20 35 29 7 - 49:41:10:0 
5 60 7 1.2 3 23 34 9  - 35:51:14:0 
6 60 2 2.4
c
 3 28 35 12 - 37:47:16:0 
7 80 2.5 4.0
d
 3 12
e
 - 14 22 25:0:29:46 
8 60 8 4.2
f
 3 4
e
 14
e 
29 15
e 
6:23:47:24 
a
 Yields after FCC purification. 
b
 During purification by FCC the column was leaking. 
c
 NaClO2 added in two batches (1.2 eq each). The second addition was done after 1 d. 
d
 Reaction performed with 3.0 eq of NaClO2 for 1 d after which 1.0 eq of NaClO2 was added. 
e
 Yields based on 
1
H NMR spectrum. 
f
 Reaction performed with 1.2 eq of NaClO2 for 1 d after which 1.0 eq of NaClO2 was added three 
times with 1 d intervals. 
50 
 
The treatment with aqueous Na2SO3 solution did not reduce the hydroperoxide 
functionality in 20, even after a prolonged time and the product distribution remained the 
same (Table 15, entries 1 and 2). Because small amounts of starting material were visible 
in the TLC analysis after one day of reaction we decided to investigate whether a longer 
reaction time would consume the substrate completely and give the products in better 
yields. A lower reaction temperature decreased the reactivity and even after three days of 
reaction a significant amount of the starting material was visible in TLC analysis (entry 3). 
This explains in part the low yield obtained for product 17 (6%) but some of the product 
was also lost during the chromatographic purification since the column was leaking in the 
beginning. Products 20 (14%) and 22 (1%) were obtained in similar yields as in the earlier 
experiments. 
The reaction at 60 °C for three days (entry 4) gave the 15-hydroperoxy-7-oxo derivative 20 
in a significantly higher proportion and after seven days (entry 5) the reaction finally gave 
compound 20 as the major product in a moderate yield (34%). At the same time we noticed 
that the purity of 17 was improved with a longer reaction time and no trace of another 
compound was visible in the 
1
H and 
13
C NMR spectra of the isolated 17. When combining 
the impure fractions of 17 of the previous reactions and repeating the chromatographic 
purification we were able to obtain pure 17, and a sample of the other compound with a 
minor contamination from 17. NMR analysis of this sample revealed a signal at 81.5 ppm 
in the 
13
C NMR spectrum. Because the value is very close to the chemical shift of C-15 
(83.8 ppm) in compound 20, we believe that the signal belongs to a carbon with a 
hydroperoxy substituent attached. However, in the 
1
H NMR spectrum the characteristic 
septet signal of 15-H at 2.87 ppm is visible. No further analysis of this impure sample was 
performed and to the best of our knowledge these signals belong to methyl 7-
hydroperoxydehydroabietate (18, Figure 6), which has been reported.
26, 31 
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Figure 6. 
1
H and 
13
C NMR spectra of impure 7-hydroperoxydehydroabietate (18). 
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Next, we explored if by increasing the amount of oxidant we could exhaust the initial 
product 17 and obtain the hydroperoxide 20 through further oxidation, in a higher yield. In 
entry 6 the oxidation of 16 was performed with 1.2 eq of NaClO2 for one day followed by 
a second addition of 1.2 eq of NaClO2 and continuing the reaction for another day. The 
results were similar to those obtained in the 7 d reaction and gave compound 20 in 35% 
yield (entry 6). 
Increasing the reaction temperature to 80 °C and using a total of 4.0 eq of NaClO2, failed 
to give any of the hydroperoxide 20 (entry 7). It is likely that the high temperature brings 
about the redox decomposition of the hydroperoxide into other products. In fact, a new 
product was isolated from the reaction mixture, in 22% yield. This compound was 
identified as methyl 13-acetyl-7-oxopodocarpa-8,11,13-trien-15-oate (23) on the basis of 
IR, NMR and HRMS analysis and comparison of the experimental data with spectral data 
reported in the literature.
53
 Product 17 was obtained as an inseparable mixture with another 
hitherto unknown compound. In the 
13
C NMR spectrum (Figure 7) of the product mixture 
two signals belonging to the second compound at 79.0 ppm and 81.1 ppm are visible, 
which are likely the chemical shifts of carbons with a hydroperoxy substituent attached. No 
further analysis of the mixture was attempted and to the best of our knowledge the second 
compound in the mixture is methyl 7,15-dihydroperoxydehydroabieate (105, Figure 7). 
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Figure 7. 
13
C NMR spectrum of 1:1 mixture of methyl 7-oxodehydroabietate (17) and methyl 7,15-
dihydroperoxydehydroabietate (105).  
Another experiment using a total of 4.2 eq of NaClO2 and a reaction time of 8 days 
afforded 15-hydroxy-7-oxo derivative 22 as the major product in 29% yield and product 20 
was obtained as an inseparable mixture together with product 23 (entry 8). The extended 
reaction time and large excess amount of the oxidant probably caused compound 20 to 
partially decompose. Methyl 7-oxodehydroabietate (17) was again obtained as an 
inseparable mixture and NMR analysis of the mixture revealed an identical spectrum as 
shown above in Figure 7. 
In addition we explored if the products 20 and/or 22 with a higher degree of oxygenation 
could be obtained in increased yields starting from methyl 7-oxodehydroabietate (17) by a 
two-step oxidation. A 3:2 mixture of 17 and 18 collected and combined from previous 
experiments was oxidized with 1.2 eq of NaClO2. TLC monitoring of the reaction showed 
that already after 10 min product 20 started forming. The reaction did not proceed 
efficiently and after 1 d 59% of 17 was recovered along with isolation of products 20 and 
22 in 24% and 4% yields. This experiment provided us with information on the reaction 
pathway since the amount of 18 had clearly diminished. Therefore, we believe that 
54 
 
compound 17 is formed via 18. This is also in agreement with the fact that compound 17 
could be obtained with improved purity when the oxidation was performed with a longer 
reaction time. 
Although we were unsuccessful in obtaining methyl 15-hydroperoxy-7-oxodehyroabietate 
(20) in a yield higher than 35% (Table 15, entry 6), we became interested to see if we 
could prepare similarly oxygenated products under these conditions starting from other 
dehydroabietic acid derivatives. To explore the scope of the reaction, four dehydroabietic 
acid derivatives with various functionalities on C-18 were selected as substrates for the 
benzylic oxidation studies and the structures are shown in Figure 8. Only dehydroabietyl 
amine (106) is commercially available and the other three compounds were prepared 
following known synthetic procedures. 
 
Figure 8. Dehydroabietic acid derivatives used as substrates in the oxidation studies. 
In previous work by our research group, the synthesis of several novel dehydroabietic acid 
derivatives by amide coupling with various amino acids has been described.
111, 112
 
Biological evaluation revealed interesting anti-biofilm and antiprotozoal activities among 
the amide derivatives. These promising results have encouraged us to continue our studies 
on this type of compounds. As a part of this ongoing work, the amide derivatives 107 and 
108 (Figure 8) were selected to be studied in the oxidation experiments in the present 
work.  
The synthesis of dehydroabietic derivatives 107, 108, and 24 are shown in Scheme 19. 
Dehydroabietyl amide (107) was synthesized from dehydroabietic acid and aqueous 
ammonia, in 81% yield, by a carbodiimide-mediated amide coupling, according to our 
reported procedure.
111
 Amide 108 was synthesized in 87% by a similar amide coupling 
reaction using glycine methyl ester hydrochloride. Dehydroabietane (24) was synthesized 
in three steps starting from dehydroabietic acid (6) according to a reported procedure.
113
 
Initial reduction with LiAlH4 gave dehydroabietinol (109), in 64% yield and tosylation of 
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109 with p-tosyl chloride afforded compound 110, in 82% yield. Finally, reductive 
desulfonylation in the presence of sodium iodide and zinc powder gave dehydroabietane 
(24), in 64% yield. All compounds were characterized by IR, NMR and HRMS analysis. 
 
Scheme 19. Synthesis of dehydroabietic acid derivatives. Reagents and conditions: (a) i. EDC, 
HOBt, DMF, rt, 1 h; ii. NH3 (25% aqueous), rt, 3 h, 81%; (b) i. EDC, HOBt, DMF, rt, 1 h; ii. 
DIPEA, glycine methyl ester hydrochloride, 87%; (c) LiAlH4, THF, Ar atmosphere, 0 °C to rt, 22 
h, 64%; (d) TsCl, pyridine, 0 °C to rt, 23 h, 82%; (e) NaI, Zn powder, DMF, 100 °C, 7 d, 64%. 
For each substrate, two oxidation experiments were performed using reaction conditions 
according to entry 1 (1.2 eq of NaClO2, reaction time 1 d), and entry 6 (2.4 eq of NaClO2 
added in two equal portions with 1 d in between, total reaction time 2 d), as in Table 15. 
The reason for choosing these conditions is that we were eager to see if our optimized 
conditions (entry 6) for obtaining the 15-hydroperoxy-7-oxo derivative as the major 
product could be repeated with the other substrates in comparison to the original conditions 
(entry 1) where the 7-oxo derivative was obtained as the major product. 
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Oxidation of dehydroabietyl amine (106) under these conditions resulted in a very complex 
product mixture containing at least 8 different compounds according to TLC analysis, and 
no pure compounds were obtained from the chromatographic purification. NMR analysis 
of the collected fractions revealed a signal at 180.5 ppm in the 
13
C NMR spectrum (Figure 
9). Thus it is likely that not only did oxidation at the benzylic positions occur but the amine 
was also oxidized into an amide. No further experiments with substrate 106 were 
performed. 
Figure 9. 
13
C NMR spectrum of a product mixture obtained from the oxidation of dehydroabietyl 
amine (106). 
Next, we turned our attention on the amides 107 and 108, and dehydroabietane (24). The 
results from the oxidation of these substrates (entries 3–8) are collected in Table 16 
together with the previous results from the oxidations of substrate 16 (entries 1 and 2). 
Interestingly, we were not able to obtain the 15-hydroperoxy-7-oxo derivative from the 
amides but rather the 15-hydroxy-7-oxo derivatives as the secondary products. Oxidation 
of dehydroabietyl amide (107) with 1.2 eq of NaClO2 for 1 d (entry 3) gave 7-
oxodehydroabietyl amide (111), in 69% yield, together with 15-hydroxy-7-
oxodehydroabietyl amide (112), in 14% yield (entry 3). Increasing the reaction time and 
amount of oxidant (entry 4) gave 112 in a higher yield (31%) while 111 was obtained in a 
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lowered yield (24%). No other products were isolated although five different products 
were seen in TLC monitoring of the reactions. Instead, traces of these compounds were 
visible as impurities in the NMR analysis of 111 and 112. The structures were confirmed 
by HRMS analysis. 
Table 16. Results from oxidation of various dehydroabietic derivatives with NaClO2 and  
t-BuOOH. 
 
Entry Substrate Time (d) NaClO2 (eq) Yields (%)
a
 
    Product A Product B Product C 
1 16 1 1.2 43 (17) 10 (20) 2 (22) 
2 16 2 2.4
b
 28 (17) 35 (20) 12 (22) 
3 107 1 1.2 69
c
 (111) - 14
c
 (112) 
4 107 2 2.4
b
 24
c
 (111) - 31
c
 (112) 
5 108 1 1.2 36 (113) - 6 (114) 
6 108 2 2.4
b
 31 (113) - 12 (114) 
7 24 1 1.2 23 (25) - - 
8 24 2 2.4
b
 17 (25) - - 
a
 Yields after FCC purification. 
b
 Reaction performed with 1.2 eq of NaClO2 for 1 d after which further 1.2 eq of NaClO2 was 
added and the reaction continued for another day. 
c
 Yields based on 
1
H NMR spectrum. 
The oxidation of substrate 108 for 1 d with 1.2 eq of NaClO2 (entry 5) did not completely 
consume the substrate and the reaction yielded the 7-oxo product 113 (36%) along with the 
minor 15-hydroxy-7-oxo product 114 (6%). A longer reaction time and increased amount 
of oxidant only slightly influenced the reaction outcome with 31% of 113 and 12% of 114 
obtained. The 15-hydroxy-7-oxo derivatives 112 and 114 of the amides 107 and 108, 
respectively, have not been reported before and we were excited to see that these novel 
compounds could be prepared by our oxidation procedure.  
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For dehydroabietane (24) the present reaction conditions proved to be too harsh. From the 
two experiments we were only able to obtain 7-oxodehydroabietane (25), in 23% yield, 
from the 1 d reaction (entry 7) and an even lower 17% yield from the 2 d reaction (entry 8). 
The structure was confirmed by IR, NMR and HRMS analysis. NMR analysis of other 
fractions collected from the chromatographic purification revealed a complex product 
mixture with hydroperoxy substituted carbon signals at 78.5 ppm, 81.9 ppm, 84.0 ppm, and 
84.1 ppm in addition to hydroxyl substituted carbon signals at 68.5 ppm and 68.6 ppm 
visible in the 
13
C NMR spectrum (Figure 10). 
Figure 10. 
13
C NMR spectrum of complex product mixture obtained from the oxidation of 
dehydroabietane (24). 
In addition, NMR analysis of other fractions obtained from the chromatographic 
purification revealed three carbonyl signals at 173.9 ppm, 186.2 ppm, and 200.0 ppm in the 
13
C NMR spectrum (Figure 11). In the 
1
H NMR spectrum we could see that the major 
compound has the 15-H proton septet intact while the 6-H and 7-H proton signals for ring 
B are missing. No further analysis of the mixture was performed but the evidence from 
NMR analysis suggests that the oxidation conditions were too harsh for substrate 24 
causing ring B degradation with both C-6 and C-7 carbons oxidizing to carbonyl level. 
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 Figure 11. 
1
H and 
13
C NMR spectra of ring B degraded product obtained from the oxidation of 
dehydroabietane (24). 
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6 Conclusions 
In the experimental part of this Master’s thesis the benzylic C–H oxidations of 
dehydroabietanes were studied with the goal to explore an environmentally friendly 
transition metal free oxidation procedure avoiding the use of noxious chromium. From our 
initial studies with methyl dehydroabietate (16) we found that sodium chlorite in the 
presence of tert-butyl hydroperoxide was a suitable oxidant system for the benzylic 
oxidation of this substrate. Oxidation of dehydroabietanes with sodium chlorite has not 
been reported before and thus we were successful in applying this methodology for 
preparing the C-7 and C-15 oxygenated dehydroabietic acid derivatives. Compared with 
other benzylic oxidation procedures for dehydroabietanes discussed in the literature part, 
the present procedure is advantageous since it is easy to operate with cheap and readily 
available oxidants of low toxicity. 
Although optimization of the procedure for substrate 16 did not result in the selective 
formation of a single product, we were able to manipulate the product outcome to some 
extent and obtain different compounds as the major products by changing the reaction 
conditions (time, temperature, amount of oxidant). Obtaining pure compounds from the 
chromatographic purification was somewhat difficult since the variously oxygenated 
products have very similar polarities. However, as we gained more experience, this task 
became more straightforward and we were able to obtain pure products that were 
successfully characterized by IR, NMR and HRMS analysis. In addition, we gained 
structural information of some side products, which were formed only in trace amounts and 
based on the NMR analysis, we were able to suggest structures for these accordingly. 
Unfortunately, the results obtained with substrate 16 could not be replicated as such with 
the other dehydroabietic acid derivatives and interestingly we were not able to obtain the 
15-hydroperoxy-7-oxo derivative from any of the other substrates. It might be that the 
hydroperoxide derivatives of the amides 107 and 108 are less stable and quickly degrade to 
other products after initial formation. Instead, from the amides 107 and 108, we managed 
to obtain two novel 15-hydroxy-7-oxo derivatives 112 and 114, respectively, which have 
not been reported before. For dehydroabietane (24) it seems like the present conditions 
were too harsh, because the NMR analysis suggested partial ring B degradation. Further 
development of the oxidation reaction with lower temperature and/or shorter reaction time 
might be beneficial for this substrate. 
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In conclusion, we have explored an unprecedented benzylic C–H oxidation procedure for 
dehydroabietanes using environmentally friendly and inexpensive sodium chlorite in 
combination with tert-butyl hydroperoxide. Moreover, two novel dehydroabietic acid 
derivatives were isolated and characterized successfully. Further investigations on the 
benzylic oxidations of other dehydroabietic derivatives with the current procedure are 
ongoing. The preparation of a manuscript based on some of the results in this thesis is also 
currently underway. In addition, the prepared oxygenated dehydroabietic acid derivatives 
are also studied for their biological activities. Finally, these products can be used as 
intermediates in the synthesis of novel dehydroabietic acid derivatives. 
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7 Experimental data 
7.1 General information 
All reagents and solvents were obtained from commercial supplier and are listed in Table 
17. They were used as such without further purification. Air and moist sensitive reactions 
were carried out under argon atmosphere in oven-dried glassware with anhydrous solvents. 
Liquids were transferred to the reaction flask with a syringe and needle through a rubber 
septum. 
The progress of the reactions was monitored by thin layer chromatography (TLC) on 
Merck 60 F254 silica gel plates (Darmstadt, Germany). Pentane, or Hex and EtOAc, or 
CHCl3 and MeOH were used as eluents. The plates were visualized in a CAMAG dual 
wavelength (254/366 nm) UV light source (Muttenz, Switzerland) and coloured with conc. 
H2SO4 in EtOH followed by heating. 
Solvents were evaporated in reduced pressure with an ethylene glycol/water-cooled Büchi 
Rotavapor R-200 (Flawil, Switzerland). The synthesized products were purified by Flash 
Column Chromatography (FCC) on silica gel with a Biotage SP1 purification system 
(Uppsala, Sweden) using SNAP 10 g, 25 g, or 50 g cartridges (10–50 mL/min flow rate) 
and a UV-detector at 254 nm. Eluents are given together with the descriptions of the 
synthetic procedures. 
IR spectra were recorded between 4000 and 650 cm
-1
 on a Bruker Vertex 70 FT-IR 
spectrometer (MA, USA) with ATR technique. The primary characterisation of the 
synthesized products was made by 
1
H and 
13
C NMR on a Varian Mercury 300 MHz 
spectrometer (Palo Alto, CA, USA) in deuterated chloroform (CDCl3) with 
tetramethylsilane (TMS) as an internal standard, obtained from Cambridge Isotope 
Laboratories. The chemical shifts (δ) are given in parts per million (ppm) relative to the 
NMR solvent signals (CDCl3 7.26 and 77.16 ppm for 
1
H and 
13
C NMR, respectively) and 
coupling constants J are given in hertz (Hz). The abbreviations s, d, t, sept, dd, brs, and m 
refer to singlet, doublet, triplet, septet, doublet of doublets, broad singlet, and multiplet, 
respectively. High resolution mass spectra (HRMS) were obtained by direct injection using 
a Waters Synapt G2 HDMS Q-TOF mass spectrometer (MA, USA) with positive mode 
ESI. 
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Table 17. Chemicals used in synthesis and their suppliers. 
Solvent/reagent Purity Supplier 
Acetic acid, AcOH 100% Merck 
Acetonitrile, CH3CN ≥ 99.9% Fluka 
Ammonium hydroxide solution > 25% NH3 in H2O  
Aqueous tert-Butyl hydroperoxide 70 wt% Aldrich 
Chloroform, CHCl3 99.0–99.4% Sigma-Aldrich 
Chromium(VI)oxide, CrO3 ≥ 98.0% Sigma-Aldrich 
Dehydroabietic acid 90% Pfaltz & Bauer 
(+)-Dehydroabietyl amine > 90.0% TCI 
Dichloromethane, CH2Cl2 ≥ 99.8% Sigma-Aldrich 
Diethyl ether, Et2O ≥ 99.8% Sigma-Aldrich 
N,N-Diisopropylethylamine, DIPEA 99.5% Sigma-Aldrich 
N-(3-Dimethylaminopropyl)-N’-ethylcarbo-
diimide hydrochloride, EDC hydrochloride 
≥ 98.0% Fluka 
N,N-Dimethylformamide, DMF 100.0% VWR 
Ethanol 96% Altia 
Ethyl Acetate, EtOAc ≥ 99.5% Sigma-Aldrich 
Glycine methyl ester hydrochloride ≥ 99% Fluka 
n-Hexane ≥ 97.0% Sigma-Aldrich 
1-Hydroxybenzotriazole hydrate, HOBt hydrate > 98.0% Fluka 
N-Hydroxyphthalimide, NHPI 97% Aldrich 
Lithium aluminum hydride, LiAlH4 95% Fluka 
Methanol ≥ 99.9% Fluka 
Methyl iodide, MeI 99% Sigma-Aldrich 
Oxone®, monopersulfate compound  Sigma-Aldrich 
n-Pentane 95% Lab-Scan 
Potassium bromide, KBr  Oriola Oy 
Potassium carbonate, K2CO3 ≥ 99.0% J.T. Baker 
Pyridine 99.8% Sigma-Aldrich 
Sodium chlorite, NaClO2 ~ 80% Fluka 
Sodium hydrogen carbonate, NaHCO3 100% VWR 
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Table 17 continues.   
Solvent/reagent Purity Supplier 
Sodium iodide ≥ 99.0% Sigma-Aldrich 
Sodium sulfate, Na2SO4 ≥ 99.0% Fluka 
Sodium sulfite, Na2SO3 98–100.0% Sigma-Aldrich 
Sodium thiosulfate, Na2S2O3 ≥ 98.0% Sigma-Aldrich 
Sulfuric acid 95.0–97.0% Sigma-Aldrich 
Tetrahydrofuran ≥ 99.9% Sigma-Aldrich 
p-Toluenesulfonyl chloride + 99% Acros Organics 
Zinc powder 99.995% Aldrich 
 
7.2 Synthesis and characterization 
Methyl abieta-8,11,13-trien-18-oate (16)  
Compound 6 (5.00 g, 16.6 mmol) was dissolved in DMF (40 mL) 
in a 100 mL two-neck flask at room temperature. Anhydrous 
K2CO3 (5.75 g, 41.6 mmol, 2.5 eq) was added followed by the 
addition of CH3I (2.07 mL, 33.3 mmol, 2.0 eq). The reaction 
mixture was stirred at room temperature for 4 h after which the 
reaction was quenched with 1 M HCl (50 mL) and diluted with 
Et2O (100 mL). The aqueous phase was extracted with Et2O (3 × 100 mL) and the 
combined organic phase was washed with 1 M HCl (50 mL), saturated NaHCO3 solution 
(50 mL), H2O (50 mL), brine (50 mL), dried over anhydrous Na2SO4, filtered and 
evaporated to dryness to afford 16 as a white solid (5.05 g, 16.1 mmol, 97%). 
1
H-NMR 
(300 MHz, CDCl3) δ 1.23 (s, 6H), 1.25 (s, 3H), 1.29 (s, 3H), 2.26 (dd, J1 = 12.5 and J2 = 
2.2 Hz, 1H), 2.31 (d, J = 12.8 Hz, 1H), 2.87 (m, 3H), 3.67 (s, 3H, OCH3), 6.89 (s, 1H, 14-
H), 7.01 (dd, J1 = 8.2 and J2 = 1.9 Hz, 1H, aromatic-H), 7.18 (d, J = 8.2 Hz, 1H, aromatic-
H). 
13
C-NMR (75 MHz, CDCl3) δ 16.7, 18.7, 21.9, 24.1, 25.2, 30.2, 33.6, 36.8, 37.1, 38.2, 
45.0, 47.8, 52.0, 124.0 (aromatic-C), 124.3 (aromatic-C), 127.0 (aromatic-C), 134.8 
(aromatic-C), 145.9 (aromatic-C), 147.1 (aromatic-C), 179.2 (C-18). IR (ATR) 2924, 2868, 
1718, (C=O), 1435, 1248 (C–O), 1175 (C–O), 1126, 824 cm-1. HRMS m/z: calcd. for 
C21H31O2 315.2324 [M+H]
+
, found 315.2323. 
All analytical data are in agreement with literature values.
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Abieta-8,11,13-trien-18-yl amide (107) 
Compound 6 (1.00 g, 3.33 mmol) was dissolved in DMF (15 mL) 
in a 50 mL two-neck flask at room temperature. EDC·HCl (0.701 
g, 3.66 mmol, 1.1 eq) and HOBt monohydrate (0.561 g, 3.66 
mmol, 1.1 eq) were added and the resulting mixture was stirred for 
1 h followed by the dropwise addition of 25% aqueous NH3 
solution (0.623 mL, 8.32 mmol, 2.5 eq). The reaction was 
completed after 3 h and quenched with H2O (50 mL). The aqueous phase was extracted 
with Et2O (3 × 100 mL) and the combined organic phase was washed with 1 M HCl (2 × 
50 mL), H2O (50 mL), brine (50 mL), dried over anhydrous Na2SO4, filtered and 
evaporated to dryness to afford the crude product (1.09 g), which was purified by FCC 
using EtOAc:Hex 5 → 100% gradient to afford compound 107 as a white solid (0.806 g, 
2.69 mmol, 81%). 
1
H-NMR (300 MHz, CDCl3) δ 1.21 (s, 3H), 1.23 (s, 6H), 1.29 (s, 3H), 
2.11 (dd, J1 = 12.4 and J2 = 2.3 Hz, 1H), 2.32 (d, J = 12.7 Hz, 1H), 2.81 (m, 1H), 2.89 (m, 
2H), 5.59 (m, 2H, NH2), 6.87 (s, 1H, 14-H), 6.99 (d, J = 8.2, 1H), 7.16 (d, J = 8.2 Hz, 1H). 
13
C-NMR (75 MHz, CDCl3) δ 16.9, 18.9, 21.3, 24.1, 24.1, 25.3, 30.1, 33.6, 37.2, 37.6, 
38.2, 45.8, 47.5, 124.0 (aromatic-C), 124.2 (aromatic-C), 127.0 (aromatic-C), 134.7 
(aromatic-C), 145.9 (aromatic-C), 147.0 (aromatic-C), 181.3 (C-18). IR (ATR) 3425 (N–H 
stretch), 3327 (N–H stretch), 2924, 2866, 1626 (C=O), 1574 (N–H bending), 1454, 821 
cm
-1
. HRMS m/z: calcd. for C20H30NO 300.2327 [M+H]
+
, found 300.2332. 
All analytical data are in agreement with literature values.
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Methyl N-(abieta-8,11,13-trien-18-oyl)glycinate (108) 
Compound 6 (1.00 g, 3.33 mmol) was dissolved in DMF (10 mL) 
in a 25 mL two-neck flask at room temperature. EDC·HCl (0.957 
g, 4.99 mmol, 1.5 eq) and HOBt monohydrate (0.764 g, 4.99 
mmol, 1.5 eq) were added and the resulting mixture was agitated 
for 1 h followed by the addition of glycine methyl ester 
hydrochloride (0.626 g, 4.99 mmol, 1.5 eq) and DIPEA (1.74 mL, 
9.99 mmol, 3.0 eq). The reaction was completed after 2 h and 
quenched with H2O (50 mL). The mixture was diluted with Et2O (100 mL) and the 
aqueous phase was extracted with Et2O (2 × 100 mL). The combined organic phase was 
washed with 1 M HCl (50 mL), saturated NaHCO3 (50 mL) solution, H2O (50 mL), brine 
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(50 mL), dried over anhydrous Na2SO4, filtered and evaporated to dryness to afford 
compound 108 as a white solid (1.08 g, 2.90 mmol, 87%). 
1
H-NMR (300 MHz, CDCl3) δ 
1.21 (s, 3H), 1.23 (s, 3H), 1.24 (s, 3H), 1.32 (s, 3H), 2.14 (dd, J1 = 12.4 and J2 = 2.3 Hz, 
1H), 2.31 (d, J = 12.8 Hz, 1H), 2.85 (m, 3H), 3.76 (s, 3H, OCH3), 4.05 (d, J = 5.1 Hz, 2H, 
NHCH2), 6.28 (brs, 1H, NH), 6.87 (s, 1H, H-14), 6.99 (d, J = 8.3, 1H, aromatic-H), 7.16 
(d, J = 8.3 Hz, 1H, aromatic-H). 
13
C-NMR (75 MHz, CDCl3) δ 16.6, 18.9, 21.3, 24.1, 24.1, 
25.4, 30.1, 33.6, 37.3, 37.4, 38.2, 41.7, 45.7, 47.5, 52.4, 124.0 (aromatic-C), 124.2 
(aromatic-C), 127.0 (aromatic-C), 134.8 (aromatic-C), 145.9 (aromatic-C), 147.0 
(aromatic-C), 170.9, 178.8 (C-18 and CO2CH3). IR (ATR) 3368 (N–H stretch), 2926, 
2868, 1755 (C=O, ester), 1639 (C=O, amide), 1516, 1436, 1204 (C–O), 1177 (C–O), 1015, 
822 cm
-1
. HRMS m/z: calcd. for C23H34NO3 372.2539 [M+H]
+
, found 372.2544. 
All analytical data are in agreement with literature values.
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8,11,13-Abietatrien-18-nol (109) 
LiAlH4 (0.505 g, 13.3 mmol, 2.0 eq) and anhydrous THF (8 mL) 
were placed in a dry 50 mL two-neck flask under argon. The 
suspension was cooled to 0°C and a solution of compound 6 (2.00 
g, 6.65 mmol) in anhydrous THF (8 mL) was added dropwise 
during 10 min, with stirring. The reaction mixture was stirred at 
0°C for 0.5 h, and at rt for 21.5 h after which the reaction was quenched by the slow 
addition of 10% aqueous H2SO4 (40 mL) at 0°C. The resulting mixture was diluted with 
Et2O (20 mL) and the phases were separated. The aqueous phase was extracted with Et2O 
(3 × 20 mL) . The combined organic phase was washed with saturated NaHCO3 (40 mL), 
brine (40 mL), dried over anhydrous Na2SO4, filtered and evaporated to afford the crude 
product as a yellow oil (1.60 g). The crude product was purified by FCC using EtOAc:Hex 
0 → 100% gradient to afford compound 109 as a pale yellow gum (1.22 g, 4.27 mmol, 
64%). 
1
H-NMR (300 MHz, CDCl3) δ 0.90 (s, 3H), 1.22 (s, 3H), 1.23 (s, 3H), 1.24 (s, 3H), 
2.29 (d, J = 12.7 Hz, 1H), 2.86 (m, 3H), 3.36 (dd, J1 = 72.2 and J2 = 10.9 Hz, 2H, CH2OH), 
6.89 (s, 1H, 14-H), 6.99 (dd, J1 = 8.3 and J2 = 2.2 Hz, 1H, aromatic-H), 7.18 (d, J = 8.3 Hz, 
1H, aromatic-H). 
13
C-NMR (75 MHz, CDCl3) δ 17.6, 18.8, 19.1, 24.1, 24.1, 25.4, 30.3, 
33.6, 35.3, 37.5, 38.0, 38.6, 44.2, 72.4 (C-18), 123.9 (aromatic-C), 124.4 (aromatic-C), 
127.0 (aromatic-C), 134.9 (aromatic-C), 145.7 (aromatic-C), 147.5 (aromatic-C). 
All analytical data are in agreement with literature values.
114
 
67 
 
8,11,13-abietatrien-18-yl 4-toluenesulfonate (110) 
To a stirred solution of compound 109 (1.21 g, 4.21 mmol) in 
pyridine (34 mL) was added p-tosyl chloride (4.82 g, 25.3 mmol, 
6.0 eq) at 0 °C and the reaction mixture was stirred at 0 °C for 5 h, 
and at rt for 18 h after which the reaction was quenched with ice 
water (30 mL). The resulting mixture was extracted with Et2O (3 × 
50 mL) and the combined organic phase was washed with 1 M 
HCl (3 × 25 mL), saturated NaHCO3 (25 mL), H2O (25 mL), brine (25 mL), dried over 
anhydrous Na2SO4 and evaporated to dryness to afford the crude product as a yellow oil 
(1.92 g). The crude product was purified by FCC using EtOAc:Hex 0 → 10% gradient to 
afford compound 110 as a white solid (1.52 g, 3.44 mmol, 82%). 
1
H-NMR (300 MHz, 
CDCl3) δ 0.89 (s, 3H), 1.18 (s, 3H), 1.21 (s, 3H), 1.24 (s, 3H), 2.25 (d, J = 12.7 Hz, 1H), 
2.46 (s, 3H, Ph-CH3), 2.82 (m, 3H), 3.72 (dd, J1 = 63.7 Hz and J2 = 9.3 Hz, 2H, CH2OTs), 
6.87 (s, 1H, 14-H), 6.98 (dd, J1 = 8.3 and J2 = 2.1 Hz, 1H, aromatic-H), 7.14 (d, J = 8.1 Hz, 
1H, aromatic-H), 7.34 (dd, J1 = 8.3 and J2 = 0.7 Hz, 2H, aromatic-H), 7.78 (d, J = 8.1 Hz, 
2H, aromatic-H). 
13
C-NMR (75 MHz, CDCl3) δ 17.3, 18.5, 19.0, 21.8, 24.1, 24.1, 25.3, 
30.0, 33.6, 35.3, 37.3, 37.5, 38.2, 43.9, 78.0 (C-18), 124.0 (aromatic-C), 124.3 (aromatic-
C), 126.9 (aromatic-C), 128.1 (aromatic-C), 129.9 (aromatic-C), 133.3 (aromatic-C), 134.6 
(aromatic-C), 144.8 (aromatic-C), 145.8 (aromatic-C), 146.9 (aromatic-C). IR (ATR) 2957, 
2932, 2870, 1358 (S=O), 1175 (S=O), 1097, 962, 814, 665 cm
-1
. HRMS m/z: calcd. for 
C27H36O3NaS 463.2283 [M+Na]
+
, found 463.2283. 
All analytical data are in agreement with literature values.
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8,11,13-Abietatriene (24) 
To a solution of compound 110 (1.42 g, 3.23 mmol) and dry NaI 
(3.59 g, 23.9 mmol, 7.4 eq) in anhydrous DMF (20 mL) was added 
Zn powder (2.11 g, 32.3 mmol, 10 eq) in four portions with 5 h, 17 
h, and 9 h in between the additions. The reaction mixture was 
stirred at 100 °C. One further portion of Zn powder (0.528 g, 8.08 
mmol, 2.5 eq) was added after 3 d of reaction. The reaction was finally stopped after a total 
reaction time of 7 d and the mixture was filtered through a celite pad. The celite was 
washed with 1 M HCl (75 mL), pentane (75 mL) and the aqueous phase was extracted with 
pentane (2 × 50 mL). The combined organic phase was washed with 1 M HCl (75 mL), 
68 
 
saturated NaHCO3 (75 mL), brine (75 mL), dried over anhydrous Na2SO4 and evaporated 
to afford the crude product as an orange oil (0.718 g). The crude product was purified by 
FCC using pentane to afford 24 as a clear oil (0.556 g, 2.05 mmol, 64%). 
1
H-NMR (300 
MHz, CDCl3) δ 0.94 (s, 3H), 0.96 (s, 3H), 1.20 (s, 3H), 1.23 (s, 3H), 1.25 (s, 3H), 2.28 (m, 
1H), 2.87 (m, 3H), 6.90 (s, 1H, H-14), 6.99 (dd, J1 = 8.3 and J2 = 1.7 Hz, 1H, aromatic-H), 
7.18 (d, J = 8.3 Hz, 1H, aromatic-H). 
13
C-NMR (75 MHz, CDCl3) δ 19.3, 19.5, 21.8, 24.1, 
24.2, 25.0, 30.7, 33.5, 33.6, 37.7, 39.0, 41.9, 50.6, 123.9 (aromatic-C), 124.4 (aromatic-C), 
127.0 (aromatic-C), 135.1 (aromatic-C), 145.6 (aromatic-C), 147.8 (aromatic-C). 
All analytical data are in agreement with literature values.
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Benzylic C–H oxidation of dehydroabietic derivatives 
Method A: Oxidation with t-BuOOH/NaClO2 
In a typical reaction, 70% aqueous t-BuOOH (1.14 mL, 7.95 mmol, 5.0 eq) was added to a 
stirred mixture of the appropriate substrate (16, 500 mg, 1.59 mmol) in CH3CN:H2O (3:1, 
20 mL) and the mixture was heated to 50 °C. After all substrate had dissolved, NaClO2 
(216 mg, 1.91 mmol, 1.2 eq) was slowly added during 15 min and the reaction mixture was 
stirred at 60 °C for 1 d after which the solvent was evaporated. The residue was dissolved 
in Et2O (50 mL), poured into 10% aqueous Na2SO3 solution (50 mL) and stirred 
vigorously for 3 h. The phases were separated and the aqueous phase was extracted with 
Et2O (3 × 50 mL). The combined organic phase was washed with saturated NaHCO3 (30 
mL), H2O (30 mL), brine (30 mL), dried over anhydrous Na2SO4 and evaporated to afford 
the crude product mixture (yellow oil, 559 mg), which was purified by FCC using 
EtOAc:Hex 0 → 60% gradient to give products 17 (yellow oil, 226 mg, 0.69 mmol, 43%), 
20 (white solid, 56 mg, 0.15 mmol, 10%) and 22 (colourless oil, 11 mg, 0.032 mmol, 2%). 
Method B: Catalytic oxidation with NHPI/NaClO2 
To a stirred solution of compound 16 (500 mg, 1.59 mmol) in CH3CN:H2O (3:1, 20 mL) 
was added NHPI (26 mg, 0.16 mmol, 0.1 eq) followed by the slow addition of NaClO2 
(216 mg, 2.39 mmol, 1.5 eq). The reaction mixture was stirred at 60 °C for 1 d. The 
workup was performed as in method A. Purification of the crude mixture gave products 17 
(pale yellow oil, 125 mg, 0.38 mmol, 24%), 20 (yellow oil, 18.5 mg, 0.051 mmol, 3%) and 
22 (colourless oil, 24.0 mg, 4%) together with recovery of the starting material 16 (66.9 
mg, 0.21 mmol, 13%). 
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Method C: Oxidation with Oxone 
To a stirred solution of 16 (0.500 g, 1.59 mmol) in CH3CN (9.5 mL) and H2O (0.8 mL) 
was added KBr (95.0 mg, 0.80 mmol, 0.5 eq) and Oxone (1.08 g, 3.50 mmol, 2.2 eq). The 
reaction mixture was stirred at 45 °C for 1 d and at 65 °C for 4 d after which the reaction 
was stopped since TLC monitoring revealed that the reaction was no longer proceeding. 
The reaction mixture was filtered and the solvent was evaporated from the filtrate. The 
residue was dissolved in EtOAc (100 mL), washed with saturated Na2S2O3 (50 mL), brine 
(50 mL), dried over anhydrous Na2SO4 and evaporated. The crude yellow oil (0.418 g) was 
purified by FCC using EtOAc:Hex 0 → 50% gradient. 1H and 13C NMR of the isolated 
fractions revealed no oxidized product and the starting material (299 mg, 0.95 mmol, 60%) 
was recovered instead. 
Method D: Oxidation with CrO3 
To a stirred solution of CrO3 (238 mg, 2.38 mmol, 1.5 eq) in EtOAc:AcOH (2:1, 7.5 mL) 
was dropwise added a solution of compound 16 (500 mg, 1.59 mmol) in AcOH (7.5 mL) at 
0 °C during 15 min. The reaction mixture was heated to 70 °C and further additions of 
CrO3 were made after 21.5 h (120 mg, 1.20 mmol, 0.75 eq) and 24 h (119 mg, 1.19 mmol, 
0.75 eq). After 26 h the reaction mixture was allowed to cool down and the solvents were 
evaporated. The residue was stirred in ice (50 mL) and CH2Cl2 (100 mL). The phases were 
separated and the aqueous phase was extracted with CH2Cl2 (2 × 75 mL). The combined 
organic phase was washed with 1 M HCl (50 mL), saturated NaHCO3 (2 × 50 mL), H2O 
(50 mL), brine (50 mL), dried over anhydrous Na2SO4 and evaporated to afford the crude 
product as a yellow oil (456 mg), which was purified by FCC using EtOAc:Hex 5 → 40% 
to give products 17 (colourless oil, 246 mg, 0.75 mmol, 47%) and 23 (white solid, 32.4 
mg, 0.099 mmol, 6%). 
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Methyl 7-oxoabieta-8,11,13-trien-18-oate (17) 
1
H-NMR (300 MHz, CDCl3) δ 1.24 (s, 3H), 1.26 (s, 6H), 1.35 (s, 
3H), 2.36 (m, 2H), 2.72 (m, 2H), 2.93 (m, 1H), 3.65 (s, 3H, OCH3), 
7.29 (d, J = 8.2 Hz, 1H, aromatic-H), 7.40 (dd, J1 = 8.2 and J2 = 
2.1 Hz, 1H, aromatic-H), 7.87 (d, J = 2.1 Hz, 1H, H-14). 
13
C-NMR 
(75 MHz, CDCl3) δ 16.6, 18.4, 23.9, 23.9, 24.0, 33.8, 36.8, 37.3, 
37.5, 38.0, 44.0, 46.9, 52.3, 123.6 (aromatic-C), 125.2 (aromatic-
C), 130.9 (aromatic-C), 132.7 (aromatic-C), 147.1 (aromatic-C), 153.1 (aromatic-C), 177.9 
(C-18), 198.6 (C-7). IR (ATR) 2955, 2872, 1724 (C=O, ester), 1680 (C=O, ketone), 1248 
(C–O), 1194 (C–O), 1178, 1111, 831 cm-1. HRMS m/z: calcd. for C21H28O3Na 351.1936 
[M+Na]
+
, found 351.1935. 
All analytical data are in agreement with literature values.
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Methyl 15-hydroperoxy-7-oxoabieta-8,11,13-trien-18-oate (20) 
1
H-NMR (300 MHz, CDCl3) δ 1.28 (s, 3H), 1.35 (s, 3H), 1.61 
(s, 6H), 2.38 (m, 2H), 2.73 (m, 2H), 3.66 (s, 3H, OCH3), 7.39 
(d, J = 8.3 Hz, 1H, aromatic-H), 7.69 (dd, J1 = 8.3 and J2 = 2.2 
Hz, 1H, aromatic-H), 8.05 (d, J = 2.2 Hz, 1H, aromatic-H). 
13
C-NMR (75 MHz, CDCl3) δ 16.6, 18.3, 23.8, 26.1, 26.2, 
36.7, 37.2, 37.6, 38.0, 43.8, 46.9, 52.4, 83.8 (C-15), 124.0 
(aromatic-C), 124.5 (aromatic-C), 131.0 (aromatic-C), 131.4 (aromatic-C), 143.3 
(aromatic-C), 154.6 (aromatic-C), 177.9 (C-18), 198.4 (C-7). IR (ATR) 3384 (br, O–H), 
2986, 2937, 2872, 1722 (C=O, ester), 1678 (C=O, ketone), 1240 (C–O), 1113, 833 cm-1. 
HRMS m/z: calcd. for C21H29O5 361.2015 [M+H]
+
, found 361.2011. 
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Methyl 15-hydroxy-7-oxoabieta-8,11,13-trien-18-oate (22) 
1
H-NMR (300 MHz, CDCl3) δ 1.27 (s, 3H), 1.35 (s, 3H), 1.58 
(s, 3H), 1.59 (s, 3H), 2.37 (m, 2H), 2.72 (m, 2H), 3.65 (s, 3H, 
OCH3), 7.36 (d, J = 8.3 Hz, 1H, aromatic-H), 7.73 (dd, J1 = 8.3 
and J2 = 2.3 Hz, 1H, aromatic-H), 8.06 (d, J = 2.1 Hz, 1H, 
aromatic-H). 
13
C-NMR (75 MHz, CDCl3) δ 16.6, 18.3, 23.8, 
31.8, 31.8, 36.7, 37.3, 37.5, 38.0, 43.9, 46.9, 52.4, 72.4 (C-15), 
123.3 (aromatic-C), 123.7 (aromatic-C), 130.7 (aromatic-C), 130.7 (aromatic-C), 147.5 
(aromatic-C), 154.0 (aromatic-C), 177.9 (C-18), 198.4 (C-7). IR (ATR) 3449 (br, O–H), 
2974, 2936, 2872, 1722 (C=O, ester), 1678 (C=O, ketone), 1236 (C–O), 1177 (C–O), 
1113, 961, 835 cm
-1
. HRMS m/z: calcd. for C21H29O4 345.2066 [M+H]
+
, found 345.2068. 
1
H NMR data are in agreement with literature values.
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Methyl 13-acetyl-7-oxopodocarpa-8,11,13-trien-15-oate (23) 
1
H-NMR (300 MHz, CDCl3) δ 1.29 (s, 3H), 1.36 (s, 3H), 2.41 (m, 
2H), 2.62 (s, 3H), 2.74 (m, 2H), 3.67 (s, 3H, OCH3), 7.49 (d, J = 
8.3 Hz, 1H, aromatic-H), 8.15 (dd, J1 = 8.3 and J2 = 2.1 Hz, 1H, 
aromatic-H), 8.54 (d, J = 2.1 Hz, 1H, aromatic-H). 
13
C-NMR (75 
MHz, CDCl3) δ 16.6, 18.2, 23.6, 26.8, 36.6, 37.1, 37.9, 38.2, 43.6, 
46.9, 52.4, 124.4 (aromatic-C), 128.2 (aromatic-C), 131.0 
(aromatic-C), 133.1 (aromatic-C), 135.6 (aromatic-C), 160.0 (aromatic-C), 177.7 
(CO2CH3), 197.3 (C=O), 197.5 (C=O). IR (ATR) 2951, 2920, 2870, 1720 (C=O, ester), 
1680 (C=O, ketone), 1238 (C–O), 1107, 845 cm-1. HRMS m/z: calcd. for 
C20H25O4 329.1753 [M+H]
+
, found 329.1756. 
All analytical data are in agreement with literature values.
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7-Oxoabieta-8,11,13-trien-18-yl amide (111) 
1
H-NMR (300 MHz, CDCl3) δ 1.23 (s, 3H), 1.25 (s, 3H), 1.26 (s, 
3H), 1.36 (s, 3H), 2.35 (d, J = 12.3 Hz, 1H), 2.49 (m, 1H), 2.68 (m, 
2H), 2.92 (sept, J = 6.9 Hz, 1H, 15-H), 5.68 (m, 2H, NH2), 7.29 (s, 
1H, aromatic-H), 7.39 (dd, J1 = 8.4 and J2 = 2.2 Hz, 1H, aromatic-
H), 7.84 (d, J = 2.2 Hz, 1H, aromatic-H). 
13
C-NMR (75 MHz, 
CDCl3) δ 16.9, 18.4, 23.8, 23.9, 24.0, 33.7, 37.2, 37.4, 37.5, 44.0, 
46.5, 123.5 (aromatic-C), 125.2 (aromatic-C), 131.0 (aromatic-C), 132.6 (aromatic-C), 
147.1 (aromatic-C), 153.1 (aromatic-C), 179.9 (C-18), 198.6 (C-7). IR (ATR) 3352 (N–H 
stretch), 3206 (N–H stretch), 2959, 2928, 2870, 1676 (C=O, ketone), 1653 (C=O, amide), 
1605 (N–H bending), 1250, 1194, 831 cm-1. HRMS m/z: calcd. for C20H28NO2 314.2120 
[M+H]
+
, found 314.2123. 
15-Hydroxy-7-oxoabieta-8,11,13-trien-18-yl amide (112) 
1
H-NMR (300 MHz, CDCl3) δ 1.27 (s, 3H), 1.37 (s, 3H), 1.57 
(s, 3H), 1.57 (s, 3H), 2.37 (d, J = 12.1 Hz, 1H), 2.50 (m, 1H), 
2.68 (m, 2H), 5.67 (m, 2H, NH2), 7.34 (d, J = 8.3 Hz, 1H, 
aromatic-H), 7.72 (dd, J1 = 8.3 and J2 = 2.2 Hz, 1H, aromatic-
H), 8.03 (d, J = 2.2 Hz, 1H, aromatic-H). 
13
C-NMR (75 MHz, 
CDCl3) δ 16.9, 18.4, 23.8, 31.8, 31.8, 37.2, 37.2, 37.5, 37.5, 
43.9, 46.5, 72.4 (C-15), 123.3 (aromatic-C), 123.6 (aromatic-C), 130.6 (aromatic-C), 130.8 
(aromatic-C), 147.6 (aromatic-C), 153.9 (aromatic-C), 179.9 (C-18), 198.4 (C-7). IR 
(ATR) 3352, 2972, 2932, 2870, 1657 (C=O), 1602 (N–H bending), 1234 (C–O), 750 cm-1. 
HRMS m/z: calcd. for C20H28O3 330.2069 [M+H]
+
, found 330.2069. 
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Methyl N-(7-oxoabieta-8,11,13-trien-18-oyl) glycinate (113) 
 1
H-NMR (300 MHz, CDCl3) δ 1.22 (s, 3H), 1.25 (s, 3H), 1.26 (s, 
3H), 1.40 (s, 3H), 2.36 (d, J = 12.0 Hz, 1H), 2.57 (m, 3H), 2.90 
(sept, J = 7.1 Hz, 1H, H-15), 3.77 (s, 3H, OCH3), 4.02 (d, J = 4.8 
Hz, 2H, NHCH2), 6.32 (brs, 1H, NH), 7.28 (d, J = 8.2 Hz, 1H, 
aromatic-H), 7.39 (dd, J1 = 8.2 and J2 = 2.1 Hz, 1H, aromatic-H), 
7.83 (d, J = 2.1 Hz, 1H, H-14). 
13
C-NMR (75 MHz, CDCl3) δ 
16.5., 18.4, 23.9, 24.0, 33.7, 36.9, 37.1, 37.4, 41.8, 44.2, 46.6, 52.6, 
123.5 (aromatic-C), 125.2 (aromatic-C), 130.9 (aromatic-C), 132.7 (aromatic-C), 147.0 
(aromatic-C), 153.1 (aromatic-C), 170.7, 177.4, (CONH and CO2CH3) 198.7 (C-7). IR 
(ATR) 3364 (N–H stretch), 2955, 2932, 1744 (C=O, ester), 1678 (C=O, ketone), 1641 
(C=O, amide), 1520, 1250 (C–O), 1196 (C–O), 1013, 833 cm-1. HRMS m/z: calcd. for 
C23H32NO4 386.2331 [M+H]
+
, found 386.2333. 
All analytical data are in agreement with literature values.
111
 
Methyl N-(15-hydroxy-7-oxoabieta-8,11,13-trien-18-oyl) glycinate (114) 
 1
H-NMR (300 MHz, CDCl3) δ 1.27 (s, 3H), 1.40 (s, 3H), 1.56 
(s, 3H), 1.57 (s, 3H), 2.37 (d, J = 12.6 Hz, 1H), 2.45 (m, 1H), 
2.67 (d, J = 14.5 Hz, 2H), 3.76 (s, 3H, OCH3), 4.02 (d, J = 5.0 
Hz, 2H, NHCH2), 6.33 (brs, 1H, NH), 7.34 (d, J = 8.3 Hz, 1H, 
aromatic-H), 7.72 (dd, J1 = 8.3 and J2 = 2.2 Hz, 1H, aromatic-
H), 8.02 (d, J = 2.2 Hz, 1H, aromatic-H). 
13
C-NMR (75 MHz, 
CDCl3) δ 16.5, 18.4, 23.8, 31.8, 31.8, 36.9, 37.1, 37.4, 37.5, 
41.8, 44.1, 46.6, 52.5, 72.4 (C-15), 123.3 (aromatic-C), 123.6 (aromatic-C), 130.6 
(aromatic-C), 130.7 (aromatic-C), 147.5 (aromatic-C), 153.9 (aromatic-C), 170.6, 177.4, 
(CONH and CO2CH3) 198.4 (C-7). IR (ATR) 3379, 2970, 2928, 1742 (C=O, ester), 1643 
(C=O), 1522, 1205 (C–O), 841 cm-1. HRMS m/z: calcd. for C23H32NO5 402.2280 [M+H]
+
, 
found 402.2282. 
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Abieta-8,11,13-trien-7-one (25) 
1
H-NMR (300 MHz, CDCl3) δ 0.94 (s, 3H), 1.00 (s, 3H), 1.24 (s, 
6H), 1.26 (s, 3H), 1.88 (dd, J1 = 13.1 and J2 = 4.8 Hz, 1H), 2.33 
(m, 1H), 2.68 (m, 2H), 2.92 (sept, J = 6.9 Hz, 1H, H-15), 7.29 (d, 
J = 8.3 Hz, 1H, aromatic-H), 7.39 (dd, J1 = 8.3 and J2 = 2.1 Hz, 
1H, aromatic-H), 7.87 (d, J = 2.1 Hz, 1H, H-14). 
13
C-NMR (75 
MHz, CDCl3) δ 19.1, 21.5, 23.5, 23.9, 24.0, 32.7, 33.4, 33.7, 36.4, 38.0, 38.1, 41.6, 49.5, 
123.8 (aromatic-C), 125.0 (aromatic-C), 130.9 (aromatic-C), 132.6 (aromatic-C), 146.8 
(aromatic-C), 153.9 (aromatic-C), 199.9 (C-7). IR (ATR) 2964, 2926, 2853, 1676 (C=O), 
1250, 1198, 841 cm
-1
. HRMS m/z: calcd. for C20H29O 285.2218 [M+H]
+
, found 285.2214. 
1
H NMR and IR data are in agreement with literature values.
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